Nitric	O
oxide	O
decreases	O
cytokine	B-protein
-induced	O
endothelial	O
activation	O
.	O

Nitric	O
oxide	O
selectively	O
reduces	O
endothelial	O
expression	O
of	O
adhesion	B-protein
molecules	I-protein
and	O
proinflammatory	B-protein
cytokines	I-protein
.	O

To	O
test	O
the	O
hypothesis	O
that	O
nitric	O
oxide	O
(	O
NO	O
)	O
limits	O
endothelial	O
activation	O
,	O
we	O
treated	O
cytokine-stimulated	B-cell_line
human	I-cell_line
saphenous	I-cell_line
vein	I-cell_line
endothelial	I-cell_line
cells	I-cell_line
with	O
several	O
NO	O
donors	O
and	O
assessed	O
their	O
effects	O
on	O
the	O
inducible	O
expression	O
of	O
vascular	B-protein
cell	I-protein
adhesion	I-protein
molecule-1	I-protein
(	O
VCAM-1	B-protein
)	O
.	O

In	O
a	O
concentration-dependent	O
manner	O
,	O
NO	O
inhibited	O
interleukin	B-protein
(	I-protein
IL	I-protein
)	I-protein
-1	I-protein
alpha-stimulated	O
VCAM-1	B-protein
expression	O
by	O
35-55	O
%	O
as	O
determined	O
by	O
cell	O
surface	O
enzyme	O
immunoassays	O
and	O
flow	O
cytometry	O
.	O

This	O
inhibition	O
was	O
paralleled	O
by	O
reduced	O
monocyte	O
adhesion	O
to	O
endothelial	O
monolayers	O
in	O
nonstatic	O
assays	O
,	O
was	O
unaffected	O
by	O
cGMP	O
analogues	O
,	O
and	O
was	O
quantitatively	O
similar	O
after	O
stimulation	O
by	O
either	O
IL-1	B-protein
alpha	I-protein
,	O
IL-1	B-protein
beta	I-protein
,	O
IL-4	B-protein
,	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
(	O
TNF	B-protein
alpha	I-protein
)	O
,	O
or	O
bacterial	O
lipopolysaccharide	O
.	O

NO	O
also	O
decreased	O
the	O
endothelial	O
expression	O
of	O
other	O
leukocyte	B-protein
adhesion	I-protein
molecules	I-protein
(	O
E-selectin	B-protein
and	O
to	O
a	O
lesser	O
extent	O
,	O
intercellular	B-protein
adhesion	I-protein
molecule-1	I-protein
)	O
and	O
secretable	O
cytokines	B-protein
(	O
IL-6	B-protein
and	O
IL-8	B-protein
)	O
.	O

Inhibition	O
of	O
endogenous	O
NO	O
production	O
by	O
L-N-monomethyl-arginine	O
also	O
induced	O
the	O
expression	O
of	O
VCAM-1	B-protein
,	O
but	O
did	O
not	O
augment	O
cytokine-induced	O
VCAM-1	B-protein
expression	O
.	O

Nuclear	O
run-on	O
assays	O
,	O
transfection	O
studies	O
using	O
various	O
VCAM-1	B-DNA
promoter	I-DNA
reporter	I-DNA
gene	I-DNA
constructs	I-DNA
,	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
indicated	O
that	O
NO	O
represses	O
VCAM-1	B-protein
gene	O
transcription	O
,	O
in	O
part	O
,	O
by	O
inhibiting	O
NF-kappa	B-protein
B	I-protein
.	O

We	O
propose	O
that	O
NO	O
's	O
ability	O
to	O
limit	O
endothelial	O
activation	O
and	O
inhibit	O
monocyte	O
adhesion	O
may	O
contribute	O
to	O
some	O
of	O
its	O
antiatherogenic	O
and	O
antiinflammatory	O
properties	O
within	O
the	O
vessel	O
wall	O
.	O

Nitric	NULL
Oxide	NULL
Decreases	NULL
Cytokine-induced	NULL
Endothelial	NULL
Activation	NULL
Nitric	NULL
Oxide	NULL
Selectively	NULL
Reduces	NULL
Endothelial	NULL
Expression	NULL
of	NULL
Adhesion	NULL
Molecules	NULL
and	NULL
Proinflammatory	NULL
Cytokines	NULL
Raffaele	NULL
De	NULL
Caterina	NULL
,	NULL
Peter	NULL
Libby	NULL
,	NULL
Hai-Bing	NULL
Peng	NULL
,	NULL
Victor	NULL
J.	NULL
Thannickal	NULL
,	NULL
Tripathi	NULL
B.	NULL
Rajavashisth	NULL
,	NULL
Michael	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
,	NULL
*	NULL
Wee	NULL
Soo	NULL
Shin	NULL
,	NULL
and	NULL
James	NULL
K.	NULL
Liao	NULL
Vascular	NULL
Medicine	NULL
and	NULL
Atherosclerosis	NULL
Unit	NULL
,	NULL
Cardiovascular	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
and	NULL
*Vascular	NULL
Research	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Abstract	NULL
To	NULL
test	NULL
the	NULL
hypothesis	NULL
that	NULL
nitric	NULL
oxide	NULL
(	NULL
NO	NULL
)	NULL
limits	NULL
endothelial	NULL
activation	NULL
,	NULL
we	NULL
treated	NULL
cytokine-stimulated	NULL
human	NULL
saphenous	NULL
vein	NULL
endothelial	NULL
cells	NULL
with	NULL
several	NULL
NO	NULL
donors	NULL
and	NULL
assessed	NULL
their	NULL
effects	NULL
on	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
.	NULL

In	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
,	NULL
NO	NULL
inhibited	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-la-stim-ulated	NULL
VCAM-1	NULL
expression	NULL
by	NULL
35-55	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
cell	NULL
surface	NULL
enzyme	NULL
immunoassays	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
paralleled	NULL
by	NULL
reduced	NULL
monocyte	NULL
adhesion	NULL
to	NULL
endothelial	NULL
monolayers	NULL
in	NULL
nonstatic	NULL
assays	NULL
,	NULL
was	NULL
unaffected	NULL
by	NULL
cGMP	NULL
analogues	NULL
,	NULL
and	NULL
was	NULL
quantitatively	NULL
similar	NULL
after	NULL
stimulation	NULL
by	NULL
either	NULL
IL-1	NULL
@	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
IL-4	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNFa	NULL
)	NULL
,	NULL
or	NULL
bacterial	NULL
lipopolysaccharide	NULL
.	NULL

NO	NULL
also	NULL
decreased	NULL
the	NULL
endothelial	NULL
expression	NULL
of	NULL
other	NULL
leukocyte	NULL
adhesion	NULL
molecules	NULL
(	NULL
E-selectin	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
)	NULL
and	NULL
secretable	NULL
cytokines	NULL
(	NULL
IL-6	NULL
and	NULL
IL-8	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
endogenous	NULL
NO	NULL
production	NULL
by	NULL
L-N-monomethyl-arginine	NULL
also	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
VCAM-1	NULL
,	NULL
but	NULL
did	NULL
not	NULL
augment	NULL
cytokine-induced	NULL
VCAM-1	NULL
expression	NULL
.	NULL

Nuclear	NULL
run-on	NULL
assays	NULL
,	NULL
transfection	NULL
studies	NULL
using	NULL
various	NULL
VCAM-1	NULL
promoter	NULL
reporter	NULL
gene	NULL
constructs	NULL
,	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
indicated	NULL
that	NULL
NO	NULL
represses	NULL
VCAM-1	NULL
gene	NULL
transcription	NULL
,	NULL
in	NULL
part	NULL
,	NULL
by	NULL
inhibiting	NULL
NF-B	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
NO	NULL
's	NULL
ability	NULL
to	NULL
limit	NULL
endothelial	NULL
activation	NULL
and	NULL
inhibit	NULL
monocyte	NULL
adhesion	NULL
may	NULL
contribute	NULL
to	NULL
some	NULL
of	NULL
its	NULL
antiatherogenic	NULL
and	NULL
antiinflammatory	NULL
properties	NULL
within	NULL
the	NULL
vessel	NULL
wall	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1995	NULL
.	NULL

96:60-68	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
nitric	NULL
oxide	NULL
«	NULL
endothelium	NULL
«	NULL
+	NULL
adhesion	NULL
molecules	NULL
©	NULL
monocytes	NULL
+	NULL
atherogenesis	NULL
This	NULL
work	NULL
was	NULL
presented	NULL
in	NULL
abstract	NULL
form	NULL
at	NULL
the	NULL
1994	NULL
Annual	NULL
Scientific	NULL
Meeting	NULL
of	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
,	NULL
on	NULL
15	NULL
November	NULL
1994	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
James	NULL
K.	NULL
Liao	NULL
,	NULL
Vascular	NULL
Medicine	NULL
and	NULL
Atherosclerosis	NULL
Unit	NULL
,	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
221	NULL
Longwood	NULL
Avenue	NULL
,	NULL
LMRC	NULL
307	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Phone	NULL
:	NULL
617-732-6628	NULL
,	NULL
FAX	NULL
:	NULL
617-732-6961	NULL
.	NULL

Raffaele	NULL
De	NULL
Caterina	NULL
's	NULL
present	NULL
address	NULL
is	NULL
CNR	NULL
Institute	NULL
of	NULL
Clinical	NULL
Physiology	NULL
,	NULL
Pisa	NULL
,	NULL
Italy	NULL
.	NULL

Victor	NULL
J.	NULL
Thannickal	NULL
's	NULL
present	NULL
address	NULL
is	NULL
Division	NULL
of	NULL
Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Medicine	NULL
,	NULL
Tufts-New	NULL
England	NULL
Medical	NULL
Center	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
.	NULL

Wee	NULL
Soo	NULL
Shin	NULL
's	NULL
present	NULL
address	NULL
is	NULL
The	NULL
Second	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Tokyo	NULL
University	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
21	NULL
November	NULL
1994	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
21	NULL
March	NULL
1995	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
0021-9738/95/07/0060/09	NULL
-	NULL
$	NULL
2.00	NULL
Volume	NULL
96	NULL
,	NULL
July	NULL
1995	NULL
,	NULL
60-68	NULL
60	NULL
De	NULL
Caterina	NULL
et	NULL
al	NULL
.	NULL

Introduction	NULL
Nitric	NULL
oxide	NULL
(	NULL
NO	NULL
)	NULL
!	NULL

or	NULL
closely	NULL
related	NULL
molecules	NULL
account	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
endothelium-derived	NULL
relaxing	NULL
factor	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

This	NULL
mediator	NULL
stimulates	NULL
guanylyl	NULL
cyclase	NULL
in	NULL
smooth	NULL
muscle	NULL
cells	NULL
leading	NULL
to	NULL
vascular	NULL
relaxation	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Besides	NULL
its	NULL
vasodilatory	NULL
ef-fects	NULL
,	NULL
NO	NULL
reportedly	NULL
has	NULL
many	NULL
antiatherogenic	NULL
properties	NULL
.	NULL

NO	NULL
reduces	NULL
platelet	NULL
aggregability	NULL
(	NULL
4	NULL
)	NULL
,	NULL
limits	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cell	NULL
proliferation	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
inhibits	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
the	NULL
endothelium	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
,	NULL
and	NULL
prevents	NULL
monocyte	NULL
chemotaxis	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Chronic	NULL
provision	NULL
of	NULL
L-arginine	NULL
in	NULL
the	NULL
diets	NULL
of	NULL
hypercholesterol-emic	NULL
rabbits	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
improve	NULL
endothelium-depen-dent	NULL
vasodilation	NULL
and	NULL
to	NULL
reduce	NULL
the	NULL
extent	NULL
of	NULL
atherosclerotic	NULL
lesions	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Local	NULL
leukocyte	NULL
recruitment	NULL
to	NULL
the	NULL
vessel	NULL
wall	NULL
is	NULL
an	NULL
early	NULL
step	NULL
in	NULL
atherogenesis	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecules	NULL
such	NULL
as	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
,	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
,	NULL
and	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ELAM-1	NULL
or	NULL
E-selectin	NULL
)	NULL
may	NULL
facilitate	NULL
recruitment	NULL
of	NULL
monocytes	NULL
and	NULL
lympho-cytes	NULL
to	NULL
sites	NULL
of	NULL
lesion	NULL
formation	NULL
(	NULL
12-15	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
factors	NULL
which	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecules	NULL
and	NULL
other	NULL
endothelial-derived	NULL
cytokines	NULL
may	NULL
be	NULL
important	NULL
in	NULL
modulating	NULL
lesion	NULL
formation	NULL
.	NULL

This	NULL
study	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
NO	NULL
can	NULL
limit	NULL
endothelial	NULL
activation	NULL
by	NULL
inhibiting	NULL
adhesion	NULL
molecule	NULL
expression	NULL
and	NULL
monocyte	NULL
adhesion	NULL
.	NULL

Methods	NULL
Reagents	NULL
.	NULL

Sodium	NULL
nitroprusside	NULL
(	NULL
SNP	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Elkins-Sinn	NULL
(	NULL
Cherry	NULL
Hill	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
and	NULL
3-morpholino	NULL
sydnonimine	NULL
(	NULL
SIN-1	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
A.	NULL
G.	NULL
Cassella	NULL
(	NULL
Frankfurt	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

S-nitroso-glutathione	NULL
(	NULL
GSNO	NULL
)	NULL
was	NULL
chemically	NULL
synthesized	NULL
from	NULL
glutathione	NULL
and	NULL
sodium	NULL
nitrite	NULL
(	NULL
Sigma	NULL
Immunochemicals	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

IL-1a	NULL
was	NULL
obtained	NULL
from	NULL
Hoffmann-La	NULL
Roche	NULL
(	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

IL-1/3	NULL
,	NULL
TNFa	NULL
,	NULL
and	NULL
IL-4	NULL
were	NULL
purchased	NULL
from	NULL
Genzyme	NULL
Corp.	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Escherichia	NULL
coli	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
Immuno-chemicals	NULL
.	NULL

Cell-permeable	NULL
superoxide	NULL
dismutase	NULL
(	NULL
SOD	NULL
)	NULL
and	NULL
catalase	NULL
coupled	NULL
to	NULL
polyethylene	NULL
glycol	NULL
(	NULL
PEG	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Sigma/Enzon	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Assays	NULL
for	NULL
IL-6	NULL
and	NULL
IL-8	NULL
were	NULL
measured	NULL
according	NULL
to	NULL
commercially	NULL
available	NULL
enzyme	NULL
immunoassay	NULL
(	NULL
EIA	NULL
)	NULL
kits	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Inc.	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
,	NULL
assayed	NULL
directly	NULL
in	NULL
human	NULL
saphenous	NULL
vein	NULL
endothelial	NULL
cell	NULL
(	NULL
HSVEC	NULL
)	NULL
supernates	NULL
.	NULL

1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltrans-ferase	NULL
;	NULL
EIA	NULL
,	NULL
enzyme	NULL
immunoassay	NULL
;	NULL
GSNO	NULL
,	NULL
S-nitroso-glutathione	NULL
;	NULL
hpf	NULL
,	NULL
high-power	NULL
field	NULL
;	NULL
HSVEC	NULL
,	NULL
human	NULL
saphenous	NULL
vein	NULL
endothelial	NULL
cells	NULL
;	NULL
ICAM-1	NULL
,	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
;	NULL
L-NAME	NULL
,	NULL
L-nitro-arginine	NULL
methyl	NULL
ester	NULL
;	NULL
L-NMA	NULL
,	NULL
L-N-monomethyl-arginine	NULL
;	NULL
NO	NULL
,	NULL
nitric	NULL
oxide	NULL
;	NULL
SIN-1	NULL
,	NULL
3-morpholino	NULL
sydnonimine	NULL
;	NULL
SNP	NULL
,	NULL
sodium	NULL
nitroprusside	NULL
;	NULL
VCAM-1	NULL
,	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

HSVEC	NULL
were	NULL
harvested	NULL
enzymatically	NULL
with	NULL
type	NULL
II	NULL
collagenase	NULL
0.1	NULL
%	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
and	NULL
maintained	NULL
in	NULL
medium	NULL
199	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
containing	NULL
Hepes	NULL
(	NULL
25	NULL
mmol/liter	NULL
)	NULL
,	NULL
heparin	NULL
(	NULL
1	NULL
%	NULL
)	NULL
,	NULL
endothelial	NULL
cell	NULL
growth	NULL
factor	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
L-glutamine	NULL
(	NULL
1	NULL
%	NULL
)	NULL
,	NULL
antibiotics	NULL
,	NULL
and	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
,	NULL
Lo-gan	NULL
,	NULL
UT	NULL
)	NULL
.	NULL

Once	NULL
grown	NULL
to	NULL
confluence	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
replated	NULL
on	NULL
low	NULL
pyrogen	NULL
fibronectin	NULL
(	NULL
1.5	NULL
ug/cm	NULL
'	NULL
)	NULL
at	NULL
20,000	NULL
cells/cm*	NULL
.	NULL

HSVEC	NULL
isolated	NULL
by	NULL
these	NULL
techniques	NULL
form	NULL
a	NULL
confluent	NULL
monolayer	NULL
of	NULL
polygonal	NULL
cells	NULL
and	NULL
express	NULL
von	NULL
Willebrand	NULL
factor	NULL
as	NULL
determined	NULL
by	NULL
their	NULL
content	NULL
of	NULL
specific	NULL
mRNA	NULL
and	NULL
immunoreactive	NULL
protein	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Cell	NULL
number	NULL
was	NULL
assessed	NULL
after	NULL
trypsinization	NULL
in	NULL
a	NULL
Neubauer	NULL
hemocytometer	NULL
(	NULL
VWR	NULL
Scientific	NULL
Corp.	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Cellular	NULL
viability	NULL
was	NULL
assessed	NULL
by	NULL
Trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Bovine	NULL
aortic	NULL
endothelial	NULL
cells	NULL
(	NULL
10°/100-mm	NULL
culture	NULL
dish	NULL
,	NULL
grown	NULL
in	NULL
DME	NULL
with	NULL
5	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
)	NULL
were	NULL
used	NULL
within	NULL
passage	NULL
3	NULL
for	NULL
transfection	NULL
experiments	NULL
.	NULL

Detection	NULL
of	NULL
cell	NULL
surface	NULL
molecules	NULL
.	NULL

Assay	NULL
of	NULL
cell	NULL
surface	NULL
molecules	NULL
was	NULL
carried	NULL
out	NULL
after	NULL
treatment	NULL
with	NULL
cytokines	NULL
and	NULL
NO	NULL
donors	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
was	NULL
determined	NULL
by	NULL
cell	NULL
surface	NULL
EIA	NULL
or	NULL
flow	NULL
cytometry	NULL
using	NULL
mouse	NULL
anti-human	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
VCAM-1	NULL
(	NULL
antibody	NULL
E1/6	NULL
)	NULL
,	NULL
E-selectin	NULL
(	NULL
Ab	NULL
H18/7	NULL
)	NULL
,	NULL
ICAM-1	NULL
(	NULL
Ab	NULL
HU	NULL
5/3	NULL
)	NULL
,	NULL
MHC-I	NULL
(	NULL
W6/32	NULL
)	NULL
(	NULL
19	NULL
)	NULL
,	NULL
or	NULL
a	NULL
constitutive	NULL
and	NULL
non-cyto-kine-inducible	NULL
endothelial	NULL
cell	NULL
antigen	NULL
(	NULL
E1/1	NULL
)	NULL
(	NULL
20	NULL
)	NULL
.	NULL

These	NULL
last	NULL
two	NULL
endothelial	NULL
surface	NULL
molecules	NULL
share	NULL
a	NULL
high	NULL
level	NULL
of	NULL
basal	NULL
constitutive	NULL
expression	NULL
,	NULL
although	NULL
MHC-I	NULL
antigen	NULL
(	NULL
Ag	NULL
)	NULL
,	NULL
at	NULL
variance	NULL
from	NULL
E1/1	NULL
Ag	NULL
,	NULL
shows	NULL
some	NULL
degree	NULL
of	NULL
inducibility	NULL
by	NULL
cytokines	NULL
.	NULL

EIA	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
incubating	NULL
monolayers	NULL
first	NULL
with	NULL
saturating	NULL
concentrations	NULL
of	NULL
specific	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
the	NULL
target	NULL
molecule	NULL
,	NULL
then	NULL
with	NULL
biotinyl-	NULL
R	NULL
,	NULL
ated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Vector	NULL
Labs	NULL
,	NULL
Inc.	NULL
,	NULL
Burlingame	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
finally	NULL
with	NULL
streptavidin-alkaline	NULL
phosphatase	NULL
(	NULL
Zymed	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Layers	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
between	NULL
each	NULL
incubation	NULL
step	NULL
,	NULL
and	NULL
integrity	NULL
of	NULL
the	NULL
monolayer	NULL
was	NULL
monitored	NULL
by	NULL
phase-contrast	NULL
microscopy	NULL
.	NULL

The	NULL
surface	NULL
expression	NULL
of	NULL
each	NULL
protein	NULL
was	NULL
quantified	NULL
spectrophotometrically	NULL
,	NULL
reading	NULL
the	NULL
optical	NULL
density	NULL
of	NULL
the	NULL
wells	NULL
(	NULL
410	NULL
nm	NULL
)	NULL
15-60	NULL
min	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
chromogenic	NULL
'	NULL
substrate	NULL
(	NULL
para-nitrophenylphosphate	NULL
)	NULL
,	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
adhesion	NULL
molecules	NULL
was	NULL
performed	NULL
by	NULL
suspending	NULL
HSVEC	NULL
in	NULL
Hanks	NULL
'	NULL
buffered	NULL
saline	NULL
solution	NULL
containing	NULL
3	NULL
mmol/liter	NULL
EDTA	NULL
and	NULL
incubating	NULL
the	NULL
cells	NULL
with	NULL
specific	NULL
primary	NULL
antibody	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
cells	NULL
are	NULL
then	NULL
exposed	NULL
to	NULL
goat	NULL
anti-mouse	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
labeled	NULL
with	NULL
fluorescein-isothiocyanate	NULL
(	NULL
Cal-tag	NULL
Laboratories	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
further	NULL
washing	NULL
,	NULL
the	NULL
cell	NULL
suspension	NULL
was	NULL
passed	NULL
through	NULL
a	NULL
FACScan®	NULL
analyzer	NULL
(	NULL
Becton-Dickinson	NULL
Immunocytometry	NULL
Systems	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
plotted	NULL
as	NULL
intensity	NULL
of	NULL
fluorescence	NULL
(	NULL
arbitrary	NULL
units	NULL
,	NULL
on	NULL
logarithmic	NULL
scale	NULL
,	NULL
on	NULL
the	NULL
abscissa	NULL
)	NULL
versus	NULL
cell	NULL
number	NULL
(	NULL
on	NULL
the	NULL
ordinate	NULL
,	NULL
total	NULL
cells	NULL
counted	NULL
,	NULL
10°	NULL
for	NULL
each	NULL
condition	NULL
)	NULL
.	NULL

Assessment	NULL
of	NULL
total	NULL
protein	NULL
synthesis	NULL
.	NULL

HSVEC	NULL
were	NULL
cultured	NULL
in	NULL
96-well	NULL
plates	NULL
and	NULL
stimulated	NULL
with	NULL
IL-la	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
NO	NULL
donors	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
the	NULL
total	NULL
cell-associated	NULL
protein	NULL
content	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
amido	NULL
black	NULL
assay	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
HSVEC	NULL
monolayers	NULL
were	NULL
fixed	NULL
with	NULL
4	NULL
%	NULL
formaldehyde	NULL
in	NULL
a	NULL
0.1	NULL
mol/	NULL
liter	NULL
acetate	NULL
buffer	NULL
,	NULL
pH	NULL
3.1	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
amido	NULL
black	NULL
B	NULL
(	NULL
Sigma	NULL
Immunochemicals	NULL
)	NULL
to	NULL
stain	NULL
cell	NULL
proteins	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Unbound	NULL
dye	NULL
was	NULL
rinsed	NULL
away	NULL
with	NULL
repeated	NULL
PBS	NULL
washings	NULL
,	NULL
and	NULL
dye	NULL
uptake	NULL
was	NULL
determined	NULL
at	NULL
620	NULL
nm	NULL
in	NULL
an	NULL
EIA	NULL
microtiter	NULL
photometer	NULL
.	NULL

In	NULL
parallel	NULL
experiments	NULL
,	NULL
dye	NULL
binding	NULL
correlated	NULL
linearly	NULL
(	NULL
r	NULL
=	NULL
0.98	NULL
)	NULL
with	NULL
cell	NULL
number	NULL
per	NULL
well	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
was	NULL
determined	NULL
by	NULL
hemocytometric	NULL
counting	NULL
of	NULL
trypsinized	NULL
cells	NULL
in	NULL
parallel	NULL
cultures	NULL
.	NULL

Preparation	NULL
of	NULL
human	NULL
monocytes	NULL
and	NULL
U937	NULL
cells	NULL
and	NULL
adhesion	NULL
assays	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
obtained	NULL
by	NULL
centrifugation	NULL
of	NULL
white	NULL
blood	NULL
cell-enriched	NULL
blood	NULL
(	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
on	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
at	NULL
15°C	NULL
(	NULL
LMS	NULL
;	NULL
Or-ganon	NULL
Teknika	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
)	NULL
followed	NULL
by	NULL
counterflow	NULL
centrifugation	NULL
elutriation	NULL
in	NULL
a	NULL
Beckman	NULL
J2-21	NULL
M/E	NULL
centrifuge	NULL
using	NULL
a	NULL
JE-6	NULL
elutriation	NULL
rotor	NULL
and	NULL
a	NULL
6-ml	NULL
Sanderson	NULL
chamber	NULL
(	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Inc.	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
modified	NULL
Doherty	NULL
's	NULL
method	NULL
was	NULL
used	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
:	NULL
the	NULL
elutriation	NULL
buffer	NULL
was	NULL
Dulbecco	NULL
's	NULL
modified	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
,	NULL
supplemented	NULL
with	NULL
3	NULL
mmol/liter	NULL
EDTA	NULL
and	NULL
0.25	NULL
%	NULL
human	NULL
serum	NULL
albumin	NULL
(	NULL
HSA	NULL
;	NULL
Sigma	NULL
Immunochemicals	NULL
)	NULL
.	NULL

The	NULL
mononuclear	NULL
cell	NULL
fraction	NULL
isolated	NULL
by	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
at	NULL
the	NULL
Ficoll-plasma	NULL
interface	NULL
was	NULL
loaded	NULL
at	NULL
14	NULL
ml/min	NULL
onto	NULL
the	NULL
elutriator	NULL
centrifuge	NULL
rotor	NULL
head	NULL
(	NULL
2,500+10	NULL
rpm	NULL
at	NULL
10°C	NULL
)	NULL
,	NULL
and	NULL
fractions	NULL
of	NULL
elutriated	NULL
cells	NULL
were	NULL
collected	NULL
.	NULL

Monocytes	NULL
were	NULL
eluted	NULL
at	NULL
21.5	NULL
ml/min	NULL
.	NULL

Monocyte	NULL
suspensions	NULL
with	NULL
this	NULL
technique	NULL
are	NULL
89+4	NULL
%	NULL
pure	NULL
with	NULL
8	NULL
%	NULL
lymphocyte	NULL
,	NULL
<	NULL
2	NULL
%	NULL
granu-locyte	NULL
,	NULL
and	NULL
essentially	NULL
no	NULL
platelet	NULL
contamination	NULL
as	NULL
determined	NULL
by	NULL
light	NULL
scatter	NULL
(	NULL
FACScan®	NULL
;	NULL
Becton	NULL
Dickinson	NULL
Immunocytometry	NULL
Systems	NULL
)	NULL
and	NULL
cell	NULL
surface	NULL
antigen	NULL
analysis	NULL
with	NULL
mAb	NULL
directed	NULL
to	NULL
CD14	NULL
.	NULL

Monocytes	NULL
were	NULL
resuspended	NULL
in	NULL
cold	NULL
Dulbecco	NULL
's	NULL
modified	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
0.75	NULL
mmol/liter	NULL
Ca**	NULL
and	NULL
0.75	NULL
mmol/liter	NULL
Mg**	NULL
and	NULL
0.2	NULL
%	NULL
HSA	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
obtained	NULL
through	NULL
American	NULL
Tissue	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Both	NULL
monocytes	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
concentrated	NULL
by	NULL
centrifugation	NULL
at	NULL
1	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

For	NULL
the	NULL
adhesion	NULL
assays	NULL
,	NULL
HSVEC	NULL
were	NULL
grown	NULL
to	NULL
confluency	NULL
in	NULL
6-well	NULL
tissue	NULL
culture	NULL
plates	NULL
,	NULL
after	NULL
which	NULL
IL-4	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
or	NULL
IL-1a	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
was	NULL
added	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
h	NULL
,	NULL
in	NULL
order	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
VCAM-1	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
GSNO	NULL
(	NULL
0.2	NULL
x	NULL
10~	NULL
'	NULL
mol/liter	NULL
)	NULL
.	NULL

For	NULL
control	NULL
,	NULL
some	NULL
monolayers	NULL
were	NULL
treated	NULL
with	NULL
a	NULL
mouse	NULL
anti-human	NULL
monoclonal	NULL
antibody	NULL
(	NULL
E1/6	NULL
)	NULL
against	NULL
VCAM-1	NULL
.	NULL

The	NULL
adhesion	NULL
assay	NULL
was	NULL
performed	NULL
by	NULL
adding	NULL
1	NULL
m	NULL
!	NULL

of	NULL
the	NULL
concentrated	NULL
monocytes	NULL
or	NULL
U937	NULL
cell	NULL
suspension	NULL
to	NULL
each	NULL
monolayer	NULL
under	NULL
rotating	NULL
conditions	NULL
(	NULL
63	NULL
rpm	NULL
)	NULL
at	NULL
21°C	NULL
.	NULL

After	NULL
10	NULL
min	NULL
,	NULL
nonadhering	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
gentle	NULL
washing	NULL
with	NULL
medium	NULL
199	NULL
,	NULL
and	NULL
monolayers	NULL
were	NULL
fixed	NULL
with	NULL
1	NULL
%	NULL
paraformalde-hyde	NULL
.	NULL

The	NULL
number	NULL
of	NULL
adherent	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
counting	NULL
six	NULL
different	NULL
high-power	NULL
fields	NULL
(	NULL
hpf	NULL
)	NULL
using	NULL
an	NULL
ocular	NULL
grid	NULL
and	NULL
a	NULL
x	NULL
20	NULL
objective	NULL
(	NULL
0.16	NULL
mm*/field	NULL
)	NULL
.	NULL

Fields	NULL
for	NULL
counting	NULL
adherent	NULL
leukocytes	NULL
were	NULL
randomly	NULL
located	NULL
at	NULL
half-radius	NULL
distance	NULL
from	NULL
the	NULL
center	NULL
of	NULL
the	NULL
monolayers	NULL
.	NULL

Northern	NULL
analysis	NULL
.	NULL

HSVEC	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
ultracentrifugation	NULL
through	NULL
CsCl	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
1.2	NULL
%	NULL
agarose-formaldehyde	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Hybond-N	NULL
;	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
immobilized	NULL
by	NULL
shortwave	NULL
ultraviolet	NULL
illumination	NULL
.	NULL

cDNA	NULL
probes	NULL
were	NULL
labeled	NULL
by	NULL
random	NULL
priming	NULL
,	NULL
[	NULL
*P	NULL
]	NULL
CTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
)	NULL
,	NULL
and	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

All	NULL
blots	NULL
were	NULL
hybridized	NULL
at	NULL
42°C	NULL
overnight	NULL
and	NULL
washed	NULL
(	NULL
0.2	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
63°C	NULL
)	NULL
before	NULL
autoradiography	NULL
at	NULL
-80°C	NULL
for	NULL
24-72	NULL
h.	NULL
Nuclear	NULL
run-on	NULL
assay	NULL
.	NULL

Nuclei	NULL
from	NULL
3-5	NULL
x	NULL
10°	NULL
endothelial	NULL
cells	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
with	NULL
[	NULL
a-	NULL
P	NULL
]	NULL
UTP	NULL
(	NULL
800	NULL
Ci/	NULL
mmol	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Linearized	NULL
plasmids	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
were	NULL
immobilized	NULL
on	NULL
nylon	NULL
membranes	NULL
,	NULL
hybridized	NULL
to	NULL
radiolabeled	NULL
transcripts	NULL
(	NULL
~	NULL
5-8	NULL
x	NULL
10	NULL
``	NULL
cpm/ml	NULL
!	NULL
)	NULL

at	NULL
45°C	NULL
for	NULL
48	NULL
h	NULL
in	NULL
hybridization	NULL
buffer	NULL
containing	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5	NULL
X	NULL
SSC	NULL
,	NULL
2.5	NULL
x	NULL
Denhardt	NULL
's	NULL
Solution	NULL
,	NULL
25	NULL
mM	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
6.5	NULL
)	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
250	NULL
mg/ml	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
washed	NULL
in	NULL
1	NULL
x	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
before	NULL
autoradiography	NULL
.	NULL

Transfections	NULL
.	NULL

The	NULL
human	NULL
VCAM-1	NULL
promoter	NULL
constructs	NULL
containing	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
were	NULL
described	NULL
previously	NULL
by	NULL
Neish	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
.	NULL

[	NULL
-755	NULL
]	NULL
FO.CAT	NULL
is	NULL
the	NULL
functional	NULL
VCAM-1	NULL
promoter	NULL
containing	NULL
AP-1	NULL
,	NULL
GATA	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

[	NULL
-98	NULL
]	NULL
F3.CAT	NULL
contains	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
without	NULL
GATA	NULL
or	NULL
AP-1	NULL
.	NULL

[	NULL
-44	NULL
]	NULL
F4.CAT	NULL
lacks	NULL
NF-	NULL
«	NULL
B	NULL
bindings	NULL
sites	NULL
.	NULL

Bovine	NULL
aortic	NULL
endothelial	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
each	NULL
reporter	NULL
plasmid	NULL
(	NULL
25	NULL
ug	NULL
)	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
(	NULL
28	NULL
)	NULL
.	NULL

As	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
pRSV.GGAL	NULL
plasmid	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
cotrans-fected	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

Preliminary	NULL
results	NULL
using	NULL
{	NULL
-galactosidase	NULL
staining	NULL
indicate	NULL
that	NULL
cellular	NULL
transfection	NULL
efficiency	NULL
was	NULL
~	NULL
12-15	NULL
%	NULL
.	NULL

Cells	NULL
(	NULL
60-70	NULL
%	NULL
confluent	NULL
)	NULL
were	NULL
stimulated	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
IL-1a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
and	NULL
TNFa	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
(	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
GSNO	NULL
[	NULL
0.2	NULL
mmol/liter	NULL
]	NULL
}	NULL
)	NULL
,	NULL
and	NULL
cellular	NULL
extracts	NULL
were	NULL
prepared	NULL
12	NULL
h	NULL
later	NULL
using	NULL
lysis	NULL
buffer	NULL
(	NULL
100	NULL
mg/ml	NULL
leupeptin	NULL
,	NULL
50	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
mM	NULL
EGTA	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
and	NULL
one	NULL
freeze-thaw	NULL
cycle	NULL
.	NULL

The	NULL
cellular	NULL
extracts	NULL
were	NULL
centrifuged	NULL
at	NULL
12,000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
subjected	NULL
to	NULL
CAT	NULL
and	NULL
/3-galactosidase	NULL
assay	NULL
.	NULL

CAT	NULL
assays	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
incubating	NULL
the	NULL
super	NULL
Nitric	NULL
Oxide	NULL
and	NULL
Endothelial	NULL
Leukocyte	NULL
Adhesion	NULL
Molecules	NULL
_	NULL
61	NULL
1004	NULL
7	NULL
L	NULL
\oj	NULL
~2	NULL
in	NULL
i	NULL
7	NULL
sms	NULL
*/*	NULL
#	NULL
tn	NULL
P	NULL
2	NULL
5-4	NULL
VCAM-1	NULL
EXPRESSION	NULL
(	NULL
%	NULL
CONTROL	NULL
)	NULL
sss	NULL
mms	NULL
mss	NULL
ww	NULL
a	NULL
105	NULL
3	NULL
x	NULL
10	NULL
10	NULL
2	NULL
x	NULL
10°	NULL
10	NULL
}	NULL
CONCENTRATION	NULL
(	NULL
mol/L	NULL
)	NULL
Figure	NULL
1	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
SNP	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
,	NULL
SIN-1	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
,	NULL
and	NULL
GSNO	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
on	NULL
IL-l1a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
-stimulated	NULL
VCAM-1	NULL
expression	NULL
.	NULL

IL-la	NULL
and	NULL
NO	NULL
donors	NULL
were	NULL
coincubated	NULL
for	NULL
24	NULL
h	NULL
before	NULL
cell	NULL
surface	NULL
EIA	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
absence	NULL
of	NULL
NO	NULL
donors	NULL
(	NULL
percentage	NULL
of	NULL
control	NULL
)	NULL
.	NULL

Original	NULL
readings	NULL
were	NULL
derived	NULL
from	NULL
four	NULL
different	NULL
experiments	NULL
each	NULL
consisting	NULL
of	NULL
=	NULL
>	NULL
12	NULL
different	NULL
replicates	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

*	NULL
Significant	NULL
difference	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
compared	NULL
with	NULL
controls	NULL
and	NULL
*	NULL
*significant	NULL
difference	NULL
(	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
compared	NULL
with	NULL
the	NULL
effects	NULL
of	NULL
SNP	NULL
and	NULL
SIN-1	NULL
at	NULL
0.4	NULL
mol/liter	NULL
.	NULL

natant	NULL
(	NULL
100	NULL
gl	NULL
)	NULL
with	NULL
[	NULL
°H	NULL
]	NULL
chloramphenicol	NULL
(	NULL
50	NULL
uCi/ml	NULL
)	NULL
and	NULL
»	NULL
-butyryl	NULL
coenzyme	NULL
A	NULL
(	NULL
250	NULL
ug/ml	NULL
)	NULL
for	NULL
20	NULL
h	NULL
at	NULL
37°C	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
n	NULL
-butyryl	NULL
[	NULL
°H	NULL
]	NULL
chloramphenicol	NULL
was	NULL
then	NULL
separated	NULL
from	NULL
unmodified	NULL
chloramphenicol	NULL
by	NULL
xylene	NULL
phase	NULL
extraction	NULL
and	NULL
counted	NULL
for	NULL
2	NULL
min	NULL
in	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
(	NULL
LS1800	NULL
;	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
calculated	NULL
from	NULL
a	NULL
standard	NULL
curve	NULL
using	NULL
various	NULL
concentrations	NULL
of	NULL
purified	NULL
CAT	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

-Galactosidase	NULL
activity	NULL
was	NULL
assayed	NULL
spectrophotometrically	NULL
(	NULL
absorption	NULL
at	NULL
410	NULL
nm	NULL
)	NULL
and	NULL
compared	NULL
with	NULL
a	NULL
standard	NULL
curve	NULL
using	NULL
known	NULL
amounts	NULL
of	NULL
purified	NULL
-galactosidase	NULL
(	NULL
Sigma	NULL
Immunochemicals	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
normalized	NULL
CAT	NULL
activity	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
CAT	NULL
to	NULL
3-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
relative	NULL
CAT	NULL
activity	NULL
was	NULL
standardized	NULL
to	NULL
the	NULL
normalized	NULL
FO.CAT	NULL
activity	NULL
having	NULL
a	NULL
value	NULL
of	NULL
100	NULL
.	NULL

Each	NULL
experiment	NULL
was	NULL
performed	NULL
three	NULL
times	NULL
in	NULL
duplicate	NULL
and	NULL
all	NULL
experiments	NULL
included	NULL
both	NULL
positive	NULL
(	NULL
highly	NULL
expressed	NULL
pSV40.CAT	NULL
)	NULL
and	NULL
negative	NULL
(	NULL
promoterless	NULL
po.CAT	NULL
)	NULL
controls	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
(	NULL
CCTGGGTITTCCC-CTTGAAGGGATITTCCCTCC	NULL
)	NULL
spanning	NULL
the	NULL
two	NULL
tandem	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
VCAM-1	NULL
promoter	NULL
(	NULL
27	NULL
)	NULL
was	NULL
synthesized	NULL
by	NULL
Genosys	NULL
Bio-technologies	NULL
,	NULL
Inc.	NULL
(	NULL
The	NULL
Woodlands	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
was	NULL
end-labeled	NULL
by	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
Inc.	NULL
,	NULL
Bev-erly	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
[	NULL
y-*P	NULL
]	NULL
ATP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
)	NULL
and	NULL
purified	NULL
by	NULL
Sephadex	NULL
G-50	NULL
columns	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
added	NULL
to	NULL
P-labeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
(	NULL
~	NULL
20,000	NULL
cpm	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
ug	NULL
poly	NULL
[	NULL
dI	NULL
+	NULL
dC	NULL
]	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Corp.	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
10	NULL
ug	NULL
BSA	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
elec-trophoresed	NULL
at	NULL
12	NULL
V/cm	NULL
in	NULL
0.5	NULL
x	NULL
TBE	NULL
.	NULL

Specificity	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
p65	NULL
or	NULL
p5O	NULL
antibodies	NULL
(	NULL
15	NULL
ug	NULL
IgG/ml	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
excess	NULL
unlabeled	NULL
(	NULL
cold	NULL
)	NULL
NF-xB	NULL
oligonucleotide	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
to	NULL
the	NULL
nuclear	NULL
extracts	NULL
for	NULL
10	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Statistics	NULL
.	NULL

Multiple	NULL
comparisons	NULL
were	NULL
performed	NULL
by	NULL
one-way	NULL
analysis	NULL
of	NULL
variance	NULL
(	NULL
ANOVA	NULL
)	NULL
and	NULL
individual	NULL
differences	NULL
tested	NULL
by	NULL
the	NULL
Fisher	NULL
's	NULL
protected	NULL
least	NULL
significance	NULL
difference	NULL
test	NULL
after	NULL
the	NULL
demonstration	NULL
of	NULL
significant	NULL
inter-group	NULL
differences	NULL
by	NULL
ANOVA	NULL
.	NULL

Student	NULL
's	NULL
?	NULL

test	NULL
for	NULL
62	NULL
De	NULL
Caterina	NULL
et	NULL
al	NULL
.	NULL

Table	NULL
I	NULL
.	NULL

Lack	NULL
of	NULL
GSNO	NULL
Effects	NULL
on	NULL
Various	NULL
Parameters	NULL
of	NULL
HSVEC	NULL
Viability	NULL
and	NULL
Protein	NULL
Expression	NULL
GSNO	NULL
Control	NULL
(	NULL
200	NULL
24	NULL
h	NULL
)	NULL
Cell	NULL
count	NULL
55+6	NULL
56+8	NULL
Viability	NULL
(	NULL
Trypan	NULL
blue	NULL
exclusion	NULL
)	NULL
>	NULL
95	NULL
%	NULL
>	NULL
95	NULL
%	NULL
Total	NULL
proteins	NULL
(	NULL
OD	NULL
mU	NULL
)	NULL
60.6+0.8	NULL
57.6+2.1	NULL
Constitutive	NULL
endothelial	NULL
cell	NULL
surface	NULL
Ag	NULL
(	NULL
OD	NULL
mU	NULL
)	NULL
MHC-1	NULL
825.5+31.8	NULL
823.0+16.7	NULL
E1/l	NULL
1726.5+51.5	NULL
1745.0+57.4	NULL
Values	NULL
are	NULL
mean	NULL
unpaired	NULL
data	NULL
was	NULL
used	NULL
to	NULL
compare	NULL
the	NULL
IL-1-stimulated	NULL
production	NULL
of	NULL
IL-6	NULL
and	NULL
IL-8	NULL
with	NULL
or	NULL
without	NULL
GSNO	NULL
.	NULL

Comparisons	NULL
of	NULL
distribution	NULL
of	NULL
fluorescent	NULL
intensities	NULL
at	NULL
flow-cytometry	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
Kolgo-morov-Smirnov	NULL
's	NULL
statistics	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Results	NULL
Three	NULL
structurally	NULL
unrelated	NULL
NO	NULL
donors	NULL
inhibit	NULL
IL-la-stimulated	NULL
VCAM-1	NULL
expression	NULL
.	NULL

SNP	NULL
,	NULL
SIN-1	NULL
,	NULL
and	NULL
GSNO	NULL
all	NULL
inhibited	NULL
IL-l1a-stimulated	NULL
expression	NULL
of	NULL
VCAM-1	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
cell	NULL
surface	NULL
EIA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Although	NULL
maximal	NULL
inhibition	NULL
of	NULL
adhesion	NULL
molecule	NULL
expression	NULL
required	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NO	NULL
donors	NULL
throughout	NULL
the	NULL
period	NULL
of	NULL
IL-la	NULL
stimulation	NULL
,	NULL
coincubation	NULL
of	NULL
NO	NULL
donors	NULL
for	NULL
periods	NULL
as	NULL
short	NULL
as	NULL
1	NULL
h	NULL
could	NULL
still	NULL
inhibit	NULL
VCAM-1	NULL
expression	NULL
,	NULL
albeit	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
HSVEC	NULL
with	NULL
various	NULL
NO	NULL
donors	NULL
for	NULL
24	NULL
h	NULL
resulted	NULL
in	NULL
significantly	NULL
different	NULL
toxicity	NULL
profiles	NULL
,	NULL
with	NULL
maximum	NULL
subtoxic	NULL
concentrations	NULL
(	NULL
concentrations	NULL
producing	NULL
<	NULL
10	NULL
%	NULL
decrease	NULL
in	NULL
either	NULL
cell	NULL
count	NULL
or	NULL
total	NULL
protein	NULL
synthesis	NULL
)	NULL
being	NULL
10~*	NULL
mol/liter	NULL
for	NULL
SNP	NULL
and	NULL
SIN-1	NULL
and	NULL
10~	NULL
'	NULL
mol/liter	NULL
for	NULL
GSNO	NULL
.	NULL

At	NULL
10	NULL
~	NULL
mol/liter	NULL
,	NULL
SNP	NULL
and	NULL
SIN-1	NULL
significantly	NULL
reduced	NULL
cell	NULL
number	NULL
counts	NULL
(	NULL
12	NULL
and	NULL
14	NULL
%	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
while	NULL
GSNO	NULL
did	NULL
not	NULL
.	NULL

GSNO	NULL
inhibited	NULL
total	NULL
protein	NULL
synthesis	NULL
(	NULL
by	NULL
9	NULL
and	NULL
19	NULL
%	NULL
)	NULL
only	NULL
at	NULL
concentrations	NULL
of	NULL
1	NULL
x	NULL
10~	NULL
and	NULL
10	NULL
x	NULL
10~	NULL
mol/liter	NULL
,	NULL
respectively	NULL
.	NULL

Because	NULL
of	NULL
its	NULL
lower	NULL
toxicity	NULL
,	NULL
most	NULL
subsequent	NULL
experiments	NULL
used	NULL
GSNO	NULL
.	NULL

NO	NULL
itself	NULL
most	NULL
likely	NULL
caused	NULL
the	NULL
inhibition	NULL
of	NULL
VCAM-1	NULL
expression	NULL
by	NULL
GSNO	NULL
,	NULL
since	NULL
neither	NULL
of	NULL
its	NULL
chemical	NULL
precursors	NULL
,	NULL
nitrite	NULL
and	NULL
glutathione	NULL
,	NULL
produced	NULL
any	NULL
inhibitory	NULL
effects	NULL
at	NULL
comparable	NULL
concentrations	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

GSNO	NULL
(	NULL
0.2	NULL
x	NULL
10~	NULL
mol/liter	NULL
)	NULL
caused	NULL
a	NULL
35-55	NULL
%	NULL
(	NULL
range	NULL
)	NULL
reduction	NULL
of	NULL
IL-la-stimulated	NULL
VCAM-1	NULL
expression	NULL
after	NULL
24	NULL
h	NULL
,	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
two	NULL
constitutive	NULL
endothelial	NULL
surface	NULL
proteins	NULL
,	NULL
E1/1	NULL
and	NULL
MHC-I	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
also	NULL
demonstrated	NULL
inhibition	NULL
of	NULL
VCAM-1	NULL
expression	NULL
by	NULL
GSNO	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Unstimulated	NULL
HSVEC	NULL
expressed	NULL
little	NULL
or	NULL
no	NULL
VCAM-1	NULL
,	NULL
as	NULL
the	NULL
distribution	NULL
of	NULL
fluorescence	NULL
intensity	NULL
compared	NULL
with	NULL
cell	NULL
number	NULL
in	NULL
such	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
overlapped	NULL
that	NULL
obtained	NULL
with	NULL
a	NULL
control	NULL
preimmune	NULL
serum	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
GSNO	NULL
did	NULL
not	NULL
affect	NULL
basal	NULL
VCAM-1	NULL
surface	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
HSVEC	NULL
with	NULL
IL-1	NULL
@	NULL
shifted	NULL
the	NULL
cell	NULL
population	NULL
to	NULL
the	NULL
right	NULL
and	NULL
widened	NULL
its	NULL
distribution	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
,	NULL
indicating	NULL
increased	NULL
VCAM-1	NULL
expression	NULL
in	NULL
the	NULL
cell	NULL
population	NULL
.	NULL

Compared	NULL
with	NULL
IL-la	NULL
alone	NULL
,	NULL
CONTROL	NULL
3.37	NULL
+	NULL
0.42	NULL
y	NULL
0	NULL
100	NULL
80	NULL
GSNO	NULL
3.85	NULL
+	NULL
0.46	NULL
CELL	NULL
___	NULL
0	NULL
NUMBER	NULL
-	NULL
80	NULL
1	NULL
c	NULL
ita	NULL
7	NULL
lmllll	NULL
13.6	NULL
£	NULL
1.6	NULL
0	NULL
10	NULL
100	NULL
80	NULL
1	NULL
D	NULL
IL-1	NULL
+	NULL
GSNO	NULL
E	NULL
10.0	NULL
+	NULL
1.4	NULL
9	NULL
o	NULL
10	NULL
100	NULL
RELATIVE	NULL
FLUORESCENCE	NULL
INTENSITY	NULL
Figure	NULL
2	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
endothelial	NULL
cells	NULL
using	NULL
antibody	NULL
to	NULL
VCAM-1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Control	NULL
(	NULL
no	NULL
IL-1a	NULL
,	NULL
no	NULL
GSNO	NULL
)	NULL
;	NULL
(	NULL
B	NULL
)	NULL
the	NULL
effect	NULL
of	NULL
GSNO	NULL
(	NULL
0.2	NULL
x	NULL
10~	NULL
mol/liter	NULL
)	NULL
after	NULL
24	NULL
h	NULL
;	NULL
(	NULL
C	NULL
)	NULL
the	NULL
effect	NULL
of	NULL
IL-l1a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
after	NULL
24	NULL
h	NULL
;	NULL
and	NULL
(	NULL
D	NULL
)	NULL
combination	NULL
of	NULL
IL-la	NULL
and	NULL
GSNO	NULL
.	NULL

Plots	NULL
represent	NULL
the	NULL
distributions	NULL
of	NULL
relative	NULL
fluorescence	NULL
intensities	NULL
(	NULL
in	NULL
arbitrary	NULL
units	NULL
,	NULL
or	NULL
``	NULL
channels	NULL
,	NULL
``	NULL
``	NULL
on	NULL
the	NULL
abscissas	NULL
,	NULL
on	NULL
a	NULL
logarithmic	NULL
scale	NULL
)	NULL
as	NULL
a	NULL
function	NULL
of	NULL
cell	NULL
number	NULL
(	NULL
on	NULL
the	NULL
ordinates	NULL
)	NULL
.	NULL

Cell	NULL
number	NULL
analyzed	NULL
in	NULL
each	NULL
condition	NULL
was	NULL
10,000	NULL
.	NULL

Insets	NULL
represent	NULL
the	NULL
median	NULL
values	NULL
of	NULL
the	NULL
distribution+	NULL
SEM	NULL
.	NULL

Panels	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
using	NULL
different	NULL
sets	NULL
of	NULL
HSVEC	NULL
monolayers	NULL
.	NULL

GSNO	NULL
,	NULL
when	NULL
added	NULL
with	NULL
IL-1a	NULL
,	NULL
shifted	NULL
the	NULL
distribution	NULL
left-ward	NULL
,	NULL
decreasing	NULL
both	NULL
its	NULL
median	NULL
value	NULL
and	NULL
its	NULL
dispersion	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
,	NULL
under	NULL
GSNO	NULL
treatment	NULL
,	NULL
fewer	NULL
cells	NULL
expressed	NULL
VCAM-1	NULL
and	NULL
,	NULL
on	NULL
the	NULL
average	NULL
,	NULL
each	NULL
cell	NULL
did	NULL
so	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
.	NULL

Controls	NULL
for	NULL
flow	NULL
cytometry	NULL
included	NULL
the	NULL
use	NULL
of	NULL
an	NULL
antibody	NULL
against	NULL
a	NULL
constitutive	NULL
and	NULL
non-cytokine-inducible	NULL
endothelial	NULL
antigen	NULL
(	NULL
Ab	NULL
E1/1	NULL
)	NULL
,	NULL
with	NULL
which	NULL
all	NULL
distributions	NULL
appeared	NULL
uniformly	NULL
shifted	NULL
to	NULL
the	NULL
right	NULL
,	NULL
and	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
which	NULL
yielded	NULL
distributions	NULL
similar	NULL
to	NULL
those	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B.	NULL
GSNO	NULL
inhibits	NULL
other	NULL
cytokine-stimulated	NULL
cell-associated	NULL
and	NULL
secreted	NULL
molecules	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
GSNO	NULL
on	NULL
other	NULL
cytokine-inducible	NULL
endothelial	NULL
proteins	NULL
,	NULL
including	NULL
two	NULL
other	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecules	NULL
,	NULL
E-selectin	NULL
and	NULL
ICAM-1	NULL
,	NULL
and	NULL
two	NULL
secretable	NULL
proteins	NULL
,	NULL
IL-6	NULL
and	NULL
IL-8	NULL
.	NULL

GSNO	NULL
inhibited	NULL
cytokine-induced	NULL
surface	NULL
expression	NULL
or	NULL
secretion	NULL
of	NULL
each	NULL
of	NULL
these	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

In	NULL
comparative	NULL
experiments	NULL
,	NULL
inhibition	NULL
of	NULL
inducible	NULL
ICAM-1	NULL
expression	NULL
,	NULL
however	NULL
,	NULL
was	NULL
negligible	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
either	NULL
VCAM-1	NULL
or	NULL
E-selectin	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

GSNO	NULL
did	NULL
not	NULL
affect	NULL
basal	NULL
(	NULL
constitutive	NULL
)	NULL
ICAM-1	NULL
expression	NULL
.	NULL

Inhibition	NULL
of	NULL
IL-8	NULL
also	NULL
was	NULL
lower	NULL
than	NULL
for	NULL
IL-6	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
indicate	NULL
that	NULL
NO	NULL
selectively	NULL
decreases	NULL
production	NULL
of	NULL
certain	NULL
cytokine-induced	NULL
molecules	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

GSNO	NULL
inhibits	NULL
VCAM-1	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
other	NULL
cytokines	NULL
.	NULL

We	NULL
assessed	NULL
and	NULL
compared	NULL
the	NULL
inhibition	NULL
of	NULL
VCAM-1	NULL
expression	NULL
by	NULL
GSNO	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
structurally	NULL
unrelated	NULL
agonists	NULL
such	NULL
as	NULL
IL-1/3	NULL
,	NULL
IL-4	NULL
,	NULL
TNFa	NULL
,	NULL
and	NULL
LPS	NULL
.	NULL

GSNO	NULL
inhibited	NULL
VCAM-1	NULL
expression	NULL
to	NULL
virtually	NULL
the	NULL
same	NULL
extent	NULL
with	NULL
each	NULL
stimulus	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
independent	NULL
of	NULL
the	NULL
relative	NULL
potency	NULL
of	NULL
the	NULL
stimulus	NULL
.	NULL

Maximum	NULL
inhibition	NULL
of	NULL
VCAM-1	NULL
by	NULL
GSNO	NULL
requires	NULL
pro	NULL
1500	NULL
-a	NULL
5531000	NULL
E	NULL
control	NULL
as	NULL
M	NULL
GSNO	NULL
&	NULL
o	NULL
5	NULL
a	NULL
3	NULL
500	NULL
$	NULL
7	NULL
*8	NULL
0	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
IL-1	NULL
VCAM-1	NULL
ICAM-1	NULL
Figure	NULL
3	NULL
.	NULL

Comparative	NULL
expression	NULL
of	NULL
VCAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
ICAM-1	NULL
in	NULL
HSVEC	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-la	NULL
(	NULL
10	NULL
ng/ml	NULL
,	NULL
24	NULL
h	NULL
)	NULL
,	NULL
with	NULL
or	NULL
without	NULL
GSNO	NULL
(	NULL
0.2	NULL
x	NULL
mol/liter	NULL
)	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
cell	NULL
surface	NULL
EIA	NULL
.	NULL

Data	NULL
represent	NULL
=	NULL
>	NULL
12	NULL
replicates	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

*	NULL
Statistically	NULL
significant	NULL
differences	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
between	NULL
groups	NULL
joined	NULL
by	NULL
the	NULL
horizontal	NULL
lines	NULL
.	NULL

E-selectin	NULL
longed	NULL
incubation	NULL
.	NULL

GSNO	NULL
inhibited	NULL
IL-1a-stimulated	NULL
VCAM-1	NULL
expression	NULL
after	NULL
1	NULL
h.	NULL
However	NULL
,	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
this	NULL
NO	NULL
donor	NULL
during	NULL
cytokine	NULL
stimulation	NULL
produced	NULL
greater	NULL
inhibition	NULL
.	NULL

In	NULL
experiments	NULL
in	NULL
which	NULL
exposure	NULL
to	NULL
the	NULL
NO	NULL
donor	NULL
was	NULL
stopped	NULL
at	NULL
various	NULL
time	NULL
points	NULL
after	NULL
the	NULL
coaddition	NULL
of	NULL
the	NULL
NO	NULL
donor	NULL
and	NULL
IL-1a	NULL
,	NULL
GSNO	NULL
inhibited	NULL
VCAM-1	NULL
expression	NULL
by	NULL
14	NULL
,	NULL
27	NULL
,	NULL
and	NULL
45	NULL
%	NULL
with	NULL
1	NULL
,	NULL
6	NULL
,	NULL
and	NULL
24	NULL
h	NULL
of	NULL
coincubation	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
SNP	NULL
and	NULL
SIN-1	NULL
at	NULL
the	NULL
same	NULL
concentrations	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
did	NULL
not	NULL
increase	NULL
beyond	NULL
the	NULL
level	NULL
observed	NULL
after	NULL
1	NULL
h	NULL
(	NULL
38	NULL
%	NULL
inhibition	NULL
)	NULL
.	NULL

GSNO	NULL
decreases	NULL
monocyte	NULL
adhesion	NULL
.	NULL

Monocytes	NULL
adhered	NULL
little	NULL
to	NULL
unstimulated	NULL
HSVEC	NULL
(	NULL
control	NULL
)	NULL
under	NULL
nonstatic	NULL
conditions	NULL
at	NULL
21°C	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
left	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
HSVEC	NULL
to	NULL
IL-la	NULL
(	NULL
10	NULL
ng/ml	NULL
,	NULL
24	NULL
h	NULL
)	NULL
increased	NULL
monocyte	NULL
adhesion	NULL
substantially	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
middle	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
HSVEC	NULL
with	NULL
GSNO	NULL
(	NULL
0.2	NULL
x	NULL
10~	NULL
mol/liter	NULL
)	NULL
inhibited	NULL
IL-1	NULL
monocyte	NULL
adhesion	NULL
by	NULL
61	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
right	NULL
)	NULL
.	NULL

IL-4	NULL
yielded	NULL
qualitatively	NULL
similar	NULL
results	NULL
(	NULL
base-line	NULL
:	NULL
2+1	NULL
cells/hpf	NULL
;	NULL
IL-4	NULL
50	NULL
ng/ml	NULL
:	NULL
27+5	NULL
cells/hpf	NULL
;	NULL
IL-4	NULL
+	NULL
GSNO	NULL
:	NULL
8+3	NULL
cells/hpf	NULL
,	NULL
corresponding	NULL
to	NULL
a	NULL
70	NULL
%	NULL
inhibition	NULL
)	NULL
.	NULL

Similar	NULL
effects	NULL
were	NULL
also	NULL
observed	NULL
for	NULL
U937	NULL
cell	NULL
adhesion	NULL
(	NULL
not	NULL
Table	NULL
II	NULL
.	NULL

The	NULL
Effect	NULL
of	NULL
NO	NULL
(	NULL
GSNO	NULL
,	NULL
200	NULL
umol/liter	NULL
,	NULL
24	NULL
h	NULL
)	NULL
on	NULL
the	NULL
Secretion	NULL
of	NULL
IL-6	NULL
and	NULL
IL-8	NULL
IL-6	NULL
IL-8	NULL
Inhibition	NULL
Inhibition	NULL
pg/10°	NULL
cells	NULL
by	NULL
GSNO	NULL
pg/10°	NULL
cells	NULL
by	NULL
GSNO	NULL
Control	NULL
,	NULL
no	NULL
IL-la	NULL
<	NULL
20	NULL
25.9+3.0	NULL
Control	NULL
+	NULL
GSNO	NULL
<	NULL
20	NULL
ND	NULL
25.8+1.3	NULL
<	NULL
1	NULL
%	NULL
IL-1a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
_	NULL
286.0+19.8	NULL
970.5+31.0	NULL
IL-la	NULL
+	NULL
GSNO	NULL
142.0+3.3*	NULL
50	NULL
%	NULL
723.1	NULL
25	NULL
%	NULL
Values	NULL
are	NULL
mean+SEM	NULL
of	NULL
protein	NULL
concentrations	NULL
assayed	NULL
in	NULL
quadruplicate	NULL
in	NULL
medium	NULL
from	NULL
greater	NULL
than	NULL
four	NULL
HSVEC	NULL
monolayers	NULL
in	NULL
each	NULL
control	NULL
unstimulated	NULL
condition	NULL
and	NULL
greater	NULL
than	NULL
eight	NULL
HSVEC	NULL
monolayers	NULL
for	NULL
each	NULL
stimulated	NULL
condition	NULL
.	NULL

Experimental	NULL
conditions	NULL
are	NULL
similar	NULL
to	NULL
what	NULL
is	NULL
described	NULL
for	NULL
assay	NULL
of	NULL
surface-associated	NULL
molecules	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
detectable	NULL
.	NULL

*	NULL
P	NULL
<	NULL
0.01	NULL
in	NULL
comparison	NULL
with	NULL
corresponding	NULL
control	NULL
condi-tions	NULL
.	NULL

Nitric	NULL
Oxide	NULL
and	NULL
Endothelial	NULL
Leukocyte	NULL
Adhesion	NULL
Molecules	NULL
__	NULL
63	NULL
1000	NULL
7	NULL
&	NULL
HE	NULL
VCAM-1	NULL
EXPRESSION	NULL
(	NULL
OD	NULL
mU	NULL
,	NULL
mean	NULL
+	NULL
SEM	NULL
)	NULL
b	NULL
S	NULL
O	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
parallel	NULL
the	NULL
decrease	NULL
in	NULL
leukocyte	NULL
adhesion	NULL
molecule	NULL
expression	NULL
caused	NULL
by	NULL
GSNO	NULL
.	NULL

Inhibition	NULL
of	NULL
VCAM-1	NULL
expression	NULL
by	NULL
GSNO	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
cGMP	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
cGMP	NULL
mediates	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
NO	NULL
donors	NULL
on	NULL
VCAM-1	NULL
levels	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effects	NULL
on	NULL
IL-la-stimulated	NULL
VCAM-1	NULL
expression	NULL
of	NULL
two	NULL
membrane-perme-able	NULL
cGMP	NULL
analogues	NULL
,	NULL
dibutyryl	NULL
cGMP	NULL
and	NULL
8-bromo	NULL
cGMP	NULL
,	NULL
in	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
from	NULL
10	NULL
~*	NULL
to	NULL
10	NULL
~	NULL
mol/liter	NULL
.	NULL

We	NULL
chose	NULL
these	NULL
concentrations	NULL
because	NULL
they	NULL
did	NULL
not	NULL
produce	NULL
toxic	NULL
effects	NULL
on	NULL
endothelial	NULL
cells	NULL
(	NULL
as	NULL
judged	NULL
by	NULL
morphology	NULL
,	NULL
Trypan	NULL
blue	NULL
exclusion	NULL
,	NULL
and	NULL
cell	NULL
counting	NULL
)	NULL
during	NULL
the	NULL
24-h	NULL
incubation	NULL
and	NULL
because	NULL
they	NULL
encompass	NULL
concentrations	NULL
able	NULL
to	NULL
mimic	NULL
vasodilatory	NULL
and	NULL
antiplatelet	NULL
effects	NULL
of	NULL
NO	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Neither	NULL
agent	NULL
reduced	NULL
IL-la-stimulated	NULL
VCAM	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
was	NULL
no	NULL
trend	NULL
toward	NULL
any	NULL
decline	NULL
over	NULL
the	NULL
entire	NULL
range	NULL
of	NULL
concentrations	NULL
explored	NULL
.	NULL

Preliminary	NULL
studies	NULL
using	NULL
metabolic	NULL
labeling	NULL
with	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
demonstrated	NULL
that	NULL
8-bromo-cGMP	NULL
(	NULL
1	NULL
x	NULL
100	NULL
mol/liter	NULL
)	NULL
was	NULL
effective	NULL
in	NULL
activating	NULL
cGMP-dependent	NULL
protein	NULL
kinase	NULL
activity	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
despite	NULL
lacking	NULL
effects	NULL
on	NULL
cytokine-induced	NULL
VCAM-1	NULL
expression	NULL
.	NULL

NO	NULL
decreases	NULL
VCAM-1	NULL
mRNA	NULL
levels	NULL
.	NULL

Northern	NULL
analysis	NULL
demonstrated	NULL
decreased	NULL
steady	NULL
state	NULL
VCAM-1	NULL
mRNA	NULL
levels	NULL
upon	NULL
incubation	NULL
with	NULL
either	NULL
SNP	NULL
or	NULL
GSNO	NULL
at	NULL
different	NULL
time	NULL
CONTROL	NULL
IL-1	NULL
2	NULL
+	NULL
1	NULL
427	NULL
+	NULL
62	NULL
I	NULL
control	NULL
M	NULL
GSNO	NULL
200	NULL
umol/L	NULL
Figure	NULL
4	NULL
.	NULL

The	NULL
inhibition	NULL
by	NULL
GSNO	NULL
(	NULL
0.2	NULL
x	NULL
10~	NULL
mol/liter	NULL
for	NULL
24	NULL
h	NULL
)	NULL
of	NULL
VCAM-1	NULL
expression	NULL
by	NULL
HSVEC	NULL
in	NULL
response	NULL
to	NULL
different	NULL
stimuli	NULL
:	NULL
IL-la	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
,	NULL
TNFa	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
,	NULL
all	NULL
administered	NULL
for	NULL
24	NULL
h.	NULL
n	NULL
=	NULL
16	NULL
for	NULL
each	NULL
different	NULL
condition	NULL
.	NULL

*	NULL
Statistically	NULL
significant	NULL
differences	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
between	NULL
groups	NULL
joined	NULL
by	NULL
the	NULL
horizontal	NULL
lines	NULL
.	NULL

points	NULL
after	NULL
IL-la	NULL
addition	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
autoradiographic	NULL
bands	NULL
showed	NULL
a	NULL
56-70	NULL
%	NULL
decrease	NULL
compared	NULL
with	NULL
control	NULL
levels	NULL
,	NULL
in	NULL
good	NULL
agreement	NULL
with	NULL
the	NULL
fall	NULL
in	NULL
protein	NULL
expression	NULL
as	NULL
quantified	NULL
by	NULL
cell	NULL
surface	NULL
EIA	NULL
.	NULL

Furthermore	NULL
,	NULL
GSNO	NULL
(	NULL
0.2	NULL
x	NULL
10	NULL
%	NULL
mol/liter	NULL
)	NULL
diminished	NULL
VCAM-1	NULL
mRNA	NULL
expression	NULL
over	NULL
a	NULL
range	NULL
of	NULL
IL-l1a	NULL
concentrations	NULL
(	NULL
0.1	NULL
100	NULL
ng/ml	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
endogenous	NULL
NO	NULL
with	NULL
L-N-monomethyl-arginine	NULL
(	NULL
L-NMA	NULL
;	NULL
1	NULL
x	NULL
10~	NULL
mol/liter	NULL
)	NULL
augmented	NULL
the	NULL
expression	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
but	NULL
had	NULL
lesser	NULL
effect	NULL
on	NULL
VCAM-1	NULL
mRNA	NULL
expression	NULL
in	NULL
TNFa-stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
C	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
expression	NULL
by	NULL
TNFa	NULL
was	NULL
blunted	NULL
by	NULL
cell-permeable	NULL
PEG-catalase	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
PEG-SOD	NULL
,	NULL
suggesting	NULL
involvement	NULL
of	NULL
hydrogen	NULL
peroxide	NULL
to	NULL
a	NULL
greater	NULL
extent	NULL
than	NULL
superoxide	NULL
anion	NULL
in	NULL
TNFa-induced	NULL
modulation	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
D	NULL
)	NULL
.	NULL

NO	NULL
decreases	NULL
cytokine-stimulated	NULL
VCAM-1	NULL
transcription	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
actinomycin	NULL
D	NULL
,	NULL
GSNO	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
half-life	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
(	NULL
5.2+1.8	NULL
h	NULL
vs.	NULL
4.7+1.5	NULL
h	NULL
,	NULL
P	NULL
=	NULL
NS	NULL
)	NULL
indicating	NULL
that	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
NO	NULL
on	NULL
VCAM-1	NULL
expression	NULL
occurs	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
.	NULL

Nuclear	NULL
run-on	NULL
assays	NULL
demonstrated	NULL
a	NULL
transcriptional	NULL
effect	NULL
of	NULL
NO	NULL
on	NULL
VCAM-1	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
)	NULL
.	NULL

Transcription	NULL
IL-1	NULL
+	NULL
GSNO	NULL
165	NULL
+	NULL
47	NULL
Figure	NULL
5	NULL
.	NULL

The	NULL
inhibition	NULL
by	NULL
GSNO	NULL
(	NULL
0.2	NULL
x	NULL
10~	NULL
mol/liter	NULL
for	NULL
24	NULL
h	NULL
)	NULL
of	NULL
monocyte	NULL
adhesion	NULL
to	NULL
HSVEC	NULL
induced	NULL
by	NULL
IL-1	NULL
,	NULL
coadministered	NULL
with	NULL
GSNO	NULL
for	NULL
24	NULL
h.	NULL
Photographs	NULL
represent	NULL
randomly	NULL
chosen	NULL
fields	NULL
at	NULL
half-radius	NULL
distance	NULL
from	NULL
the	NULL
center	NULL
of	NULL
the	NULL
well	NULL
in	NULL
one	NULL
of	NULL
three	NULL
similar	NULL
comparative	NULL
experiments	NULL
.	NULL

Insets	NULL
represent	NULL
monocyte	NULL
cell	NULL
counts+SEM	NULL
(	NULL
r	NULL
=	NULL
6	NULL
for	NULL
each	NULL
condition	NULL
)	NULL
within	NULL
a	NULL
high-power	NULL
field	NULL
(	NULL
magnification	NULL
grid	NULL
area	NULL
of	NULL
0.16	NULL
mm	NULL
)	NULL
.	NULL

64	NULL
De	NULL
Caterina	NULL
et	NULL
al	NULL
.	NULL

A	NULL
GsNo	NULL
SNP	NULL
Relative	NULL
Intensity	NULL
0.3	NULL
1.0	NULL
0.3	NULL
1.0	NULL
7.1	NULL
15.9	NULL
VCAM-1	NULL
-	NULL
»	NULL
28	NULL
S	NULL
-	NULL
»	NULL
time	NULL
after	NULL
IL-10	NULL
(	NULL
h	NULL
)	NULL
1	NULL
6	NULL
1	NULL
6	NULL
D	NULL
285	NULL
Control	NULL
188	NULL
f	NULL
i	NULL
an	NULL
285	NULL
__	NULL
L-NMA	NULL
.	NULL

(	NULL
E	NULL
sop	NULL
188	NULL
TNFa	NULL
:	NULL
-	NULL
#	NULL
#	NULL
ing	NULL
1	NULL
28S	NULL
Catalase	NULL
TNFo	NULL
.	NULL

+	NULL
L-NMA	NULL
-	NULL
ge	NULL
0	NULL
0.5	NULL
2	NULL
6	NULL
12	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
«	NULL
W-	NULL
0	NULL
0.5	NULL
2	NULL
6	NULL
12	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
B	NULL
285	NULL
-~GSNO	NULL
188	NULL
Figure	NULL
6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Northern	NULL
analyses	NULL
(	NULL
20	NULL
ug	NULL
total	NULL
RNA	NULL
/lane	NULL
)	NULL
showing	NULL
time-dependent	NULL
effects	NULL
of	NULL
SNP	NULL
(	NULL
10~*	NULL
mol/liter	NULL
)	NULL
and	NULL
GSNO	NULL
(	NULL
10~*	NULL
mol/liter	NULL
)	NULL
on	NULL
IL-1a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
-induced	NULL
VCAM-1	NULL
mRNA	NULL
levels	NULL
.	NULL

Band	NULL
'	NULL
intensities	NULL
were	NULL
analyzed	NULL
by	NULL
densitometry	NULL
and	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
band	NULL
intensity	NULL
corresponding	NULL
to	NULL
IL-la-induced	NULL
expression	NULL
of	NULL
VCAM-1	NULL
at	NULL
1	NULL
h	NULL
for	NULL
each	NULL
set	NULL
of	NULL
experiments	NULL
(	NULL
relative	NULL
intensity	NULL
)	NULL
.	NULL

The	NULL
lower	NULL
panel	NULL
shows	NULL
the	NULL
corresponding	NULL
ethid-ium	NULL
bromide	NULL
staining	NULL
for	NULL
28	NULL
S	NULL
ribosomal	NULL
RNA	NULL
.	NULL

Three	NULL
separate	NULL
experiments	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
analyses	NULL
(	NULL
20	NULL
ug	NULL
total	NULL
RNA	NULL
/lane	NULL
)	NULL
showing	NULL
concentration-dependent	NULL
effects	NULL
of	NULL
IL-1a	NULL
on	NULL
VCAM-1	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
GSNO	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
.	NULL

Another	NULL
independent	NULL
experiment	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Northern	NULL
analyses	NULL
showing	NULL
time-dependent	NULL
effects	NULL
of	NULL
L-NMA	NULL
(	NULL
1	NULL
mM	NULL
,	NULL
20	NULL
ug	NULL
total	NULL
RNA	NULL
/	NULL
lane	NULL
)	NULL
or	NULL
TNFa	NULL
(	NULL
10	NULL
ng/ml	NULL
,	NULL
10	NULL
ug	NULL
total	NULL
RNA	NULL
/lane	NULL
)	NULL
alone	NULL
,	NULL
or	NULL
in	NULL
combination	NULL
(	NULL
10	NULL
ug	NULL
total	NULL
RNA	NULL
/	NULL
lane	NULL
)	NULL
,	NULL
on	NULL
VCAM-1	NULL
mRNA	NULL
ex	NULL
285	NULL
+GSNO	NULL
188	NULL
IL-10	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
0	NULL
0.1	NULL
1.0	NULL
10	NULL
100	NULL
pression	NULL
.	NULL

Another	NULL
independent	NULL
experiment	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Northern	NULL
analyses	NULL
(	NULL
20	NULL
ug	NULL
total	NULL
RNA/lane	NULL
)	NULL
showing	NULL
time-dependent	NULL
effects	NULL
of	NULL
TNFa	NULL
(	NULL
Control	NULL
)	NULL
on	NULL
VCAM-1	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PEG-SOD	NULL
(	NULL
3,000	NULL
U/ml	NULL
)	NULL
or	NULL
PEG-catalase	NULL
(	NULL
40,000	NULL
U/ml	NULL
)	NULL
.	NULL

Another	NULL
separate	NULL
experiment	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

of	NULL
the	NULL
3-tubulin	NULL
gene	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
and	NULL
lack	NULL
of	NULL
hybridization	NULL
to	NULL
the	NULL
insertless	NULL
vector	NULL
,	NULL
pGEM	NULL
,	NULL
established	NULL
specificity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
localize	NULL
possible	NULL
sites	NULL
of	NULL
inhibition	NULL
on	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
by	NULL
NO	NULL
,	NULL
we	NULL
performed	NULL
transfection	NULL
studies	NULL
with	NULL
various	NULL
deletional	NULL
promoter	NULL
reporter	NULL
CAT	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
A	NULL
)	NULL
using	NULL
bovine	NULL
aortic	NULL
endothelial	NULL
cells	NULL
which	NULL
yielded	NULL
a	NULL
higher	NULL
transfection	NULL
efficiency	NULL
than	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
promoterless	NULL
po.CAT	NULL
and	NULL
the	NULL
highly	NULL
expressed	NULL
pSV40.CAT	NULL
served	NULL
as	NULL
negative	NULL
and	NULL
positive	NULL
controls	NULL
in	NULL
the	NULL
reporter	NULL
assays	NULL
.	NULL

The	NULL
promoterless	NULL
po.CAT	NULL
and	NULL
pF4.CAT	NULL
produced	NULL
essentially	NULL
no	NULL
relative	NULL
CAT	NULL
activity	NULL
either	NULL
basally	NULL
or	NULL
after	NULL
stimulation	NULL
with	NULL
TNFa	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
B	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
TNFa	NULL
of	NULL
transfectants	NULL
containing	NULL
the	NULL
fully	NULL
functional	NULL
VCAM-1	NULL
promoter	NULL
,	NULL
FO	NULL
,	NULL
increased	NULL
relative	NULL
CAT	NULL
activity	NULL
from	NULL
101+16	NULL
to	NULL
1,240+235	NULL
.	NULL

Cotreatment	NULL
with	NULL
GSNO	NULL
resulted	NULL
in	NULL
a	NULL
76	NULL
%	NULL
decrease	NULL
in	NULL
relative	NULL
CAT	NULL
activity	NULL
(	NULL
300+63	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
NO	NULL
can	NULL
inhibit	NULL
TNFa-stimulated	NULL
VCAM-1	NULL
promoter	NULL
activity	NULL
.	NULL

Transfection	NULL
studies	NULL
were	NULL
also	NULL
performed	NULL
using	NULL
pF3.CAT	NULL
,	NULL
_	NULL
a	NULL
deletional	NULL
VCAM-1	NULL
promoter	NULL
construct	NULL
containing	NULL
two	NULL
tandem	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
but	NULL
no	NULL
AP-1	NULL
and	NULL
GATA	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
B	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
pF3.CAT	NULL
transfectants	NULL
with	NULL
IL-la	NULL
and	NULL
TNFa	NULL
increased	NULL
relative	NULL
CAT	NULL
activity	NULL
from	NULL
73+23	NULL
to	NULL
474+52	NULL
,	NULL
suggesting	NULL
that	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
VCAM-1	NULL
transcriptional	NULL
activity	NULL
,	NULL
albeit	NULL
at	NULL
a	NULL
significantly	NULL
lower	NULL
level	NULL
compared	NULL
with	NULL
pFO.CAT	NULL
.	NULL

Cotreatment	NULL
with	NULL
GSNO	NULL
reduced	NULL
the	NULL
relative	NULL
CAT	NULL
activity	NULL
of	NULL
pF3.CAT	NULL
transfectants	NULL
to	NULL
basal	NULL
levels	NULL
(	NULL
139+51	NULL
)	NULL
.	NULL

NO	NULL
inhibits	NULL
NF-KB	NULL
activation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NO	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
radiolabeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
two	NULL
tandem	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

GSNO	NULL
(	NULL
0.2	NULL
x	NULL
107	NULL
mol/liter	NULL
)	NULL
decreased	NULL
the	NULL
amount	NULL
of	NULL
shifted	NULL
complex	NULL
induced	NULL
by	NULL
TNFa	NULL
,	NULL
indicating	NULL
that	NULL
NO	NULL
inhibits	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
shifted	NULL
complexes	NULL
were	NULL
specific	NULL
for	NULL
NF-KB	NULL
since	NULL
they	NULL
were	NULL
supershifted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
and	NULL
disappeared	NULL
with	NULL
excess	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
neither	NULL
8-bromo-cGMP	NULL
(	NULL
1	NULL
xX	NULL
10~	NULL
mol/liter	NULL
)	NULL
,	NULL
glutathione	NULL
(	NULL
0.2	NULL
x	NULL
10~	NULL
``	NULL
mol/liter	NULL
)	NULL
,	NULL
nor	NULL
nitrite	NULL
(	NULL
0.2	NULL
x	NULL
10~	NULL
mol/liter	NULL
)	NULL
had	NULL
any	NULL
effects	NULL
on	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Discussion	NULL
We	NULL
have	NULL
shown	NULL
that	NULL
NO	NULL
can	NULL
reduce	NULL
cytokine-induced	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
pathophysiologically	NULL
relevant	NULL
effector	NULL
molecules	NULL
characteristic	NULL
of	NULL
endothelial	NULL
activation	NULL
.	NULL

Upon	NULL
appropriate	NULL
stimulation	NULL
,	NULL
the	NULL
endothelium	NULL
exhibits	NULL
increased	NULL
adhesiveness	NULL
for	NULL
monocytes	NULL
,	NULL
lymphocytes	NULL
,	NULL
and	NULL
granulocytes	NULL
.	NULL

Increased	NULL
or	NULL
newly	NULL
induced	NULL
expression	NULL
of	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecules	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
ICAM-1	NULL
,	NULL
VCAM-1	NULL
,	NULL
and	NULL
E-selectin	NULL
)	NULL
mediates	NULL
such	NULL
enhanced	NULL
adhesive	NULL
interactions	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
secre-	NULL
Nitric	NULL
Oxide	NULL
and	NULL
Endothelial	NULL
Leukocyte	NULL
Adhesion	NULL
Molecules	NULL
65	NULL
3	NULL
>	NULL
1.0	NULL
ia	NULL
E	NULL
an	NULL
<	NULL
Z	NULL
§	NULL
o.s	NULL
C4	NULL
8	NULL
z	NULL
jund	NULL
wal	NULL
L	NULL
®	NULL
22	NULL
9	NULL
a	NULL
_	NULL
ud	NULL
g	NULL
0.1	NULL
O	NULL
IL-	NULL
W/GSNO	NULL
0.05	NULL
e	NULL
r	NULL
r	NULL
1	NULL
0	NULL
3	NULL
6	NULL
9	NULL
12	NULL
TIME	NULL
(	NULL
b	NULL
)	NULL
B	NULL
Figure	NULL
7	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Half-life	NULL
of	NULL
VCAM-1	NULL
-	NULL
»	NULL
IL-1a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
-stim-ulated	NULL
VCAM-1	NULL
mRNA	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
GSNO	NULL
(	NULL
0.2	NULL
x	NULL
10	NULL
~	NULL
mol/liter	NULL
)	NULL
.	NULL

Actinomycin	NULL
D	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
and	NULL
GSNO	NULL
were	NULL
added	NULL
3.5	NULL
and	NULL
4	NULL
h	NULL
after	NULL
IL-l	NULL
«	NULL
stimulation	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
(	NULL
by	NULL
densi-tometry	NULL
)	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
at	NULL
4	NULL
h	NULL
after	NULL
IL-la	NULL
stimulation	NULL
(	NULL
relative	NULL
intensity	NULL
)	NULL
and	NULL
plotted	NULL
as	NULL
a	NULL
logarithmic	NULL
function	NULL
of	NULL
time	NULL
(	NULL
h	NULL
)	NULL
.	NULL

Time	NULL
0	NULL
corresponds	NULL
to	NULL
4	NULL
h	NULL
after	NULL
IL-la	NULL
stimulation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
run-on	NULL
assay	NULL
showing	NULL
the	NULL
effects	NULL
of	NULL
NO	NULL
(	NULL
GSNO	NULL
,	NULL
0.2	NULL
x	NULL
10~	NULL
mol/liter	NULL
)	NULL
on	NULL
TNFa-stimulated	NULL
VCAM-1	NULL
gene	NULL
transcription	NULL
at	NULL
4	NULL
h.	NULL
Band	NULL
intensities	NULL
were	NULL
normalized	NULL
to	NULL
that	NULL
of	NULL
3-tubulin	NULL
.	NULL

There	NULL
were	NULL
no	NULL
bands	NULL
observed	NULL
with	NULL
linearized	NULL
pGEM	NULL
plasmid	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
is	NULL
representative	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

B-Tubulin	NULL
-	NULL
#	NULL
»	NULL
CONTROL	NULL
TNFa	NULL
TNFa	NULL
+NO	NULL
tion	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
(	NULL
IL-6	NULL
)	NULL
(	NULL
34	NULL
)	NULL
and	NULL
of	NULL
leukocyte	NULL
specific	NULL
chemoattractants	NULL
,	NULL
such	NULL
as	NULL
IL-8	NULL
and	NULL
MCP-1	NULL
,	NULL
also	NULL
likely	NULL
contributes	NULL
to	NULL
leukocyte	NULL
recruitment	NULL
during	NULL
inflammatory	NULL
responses	NULL
in	NULL
vivo	NULL
(	NULL
23	NULL
,	NULL
35	NULL
)	NULL
.	NULL

NO	NULL
significantly	NULL
inhibits	NULL
the	NULL
expression	NULL
of	NULL
VCAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
IL-6	NULL
,	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
IL-8	NULL
and	NULL
ICAM-1	NULL
.	NULL

Three	NULL
structurally	NULL
different	NULL
NO	NULL
donors	NULL
inhibited	NULL
cytokine-induced	NULL
VCAM-1	NULL
expression	NULL
and	NULL
concomitantly	NULL
reduced	NULL
monocyte	NULL
adhesion	NULL
to	NULL
cultured	NULL
endothelial	NULL
monolayers	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
effects	NULL
of	NULL
nitrite	NULL
or	NULL
glutathione	NULL
renders	NULL
it	NULL
unlikely	NULL
that	NULL
our	NULL
findings	NULL
were	NULL
due	NULL
to	NULL
mediators	NULL
other	NULL
than	NULL
NO	NULL
.	NULL

The	NULL
physiologic	NULL
relevance	NULL
of	NULL
NO	NULL
's	NULL
inhibitory	NULL
effects	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
inhibition	NULL
of	NULL
endogenous	NULL
NO	NULL
by	NULL
L-NMA	NULL
can	NULL
also	NULL
lead	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
VCAM-1	NULL
expression	NULL
,	NULL
albeit	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
compared	NULL
with	NULL
cytokine	NULL
activation	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
endogenous	NULL
endothelial	NULL
NO	NULL
production	NULL
tonically	NULL
inhibits	NULL
VCAM-1	NULL
expression	NULL
in	NULL
endothelial	NULL
cell	NULL
cultures	NULL
.	NULL

Because	NULL
induction	NULL
with	NULL
cytokines	NULL
results	NULL
in	NULL
much	NULL
higher	NULL
levels	NULL
of	NULL
VCAM-1	NULL
expression	NULL
compared	NULL
with	NULL
L-NMA	NULL
,	NULL
L-NMA	NULL
produced	NULL
only	NULL
a	NULL
small	NULL
augmentation	NULL
of	NULL
VCAM-1	NULL
expression	NULL
in	NULL
cytokine-induced	NULL
endothelial	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
agree	NULL
with	NULL
our	NULL
finding	NULL
that	NULL
endogenous	NULL
levels	NULL
of	NULL
NO	NULL
are	NULL
not	NULL
sufficient	NULL
in	NULL
limiting	NULL
cytokine-induced	NULL
VCAM-1	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
,	NULL
several	NULL
cell	NULL
types	NULL
such	NULL
as	NULL
macrophages	NULL
and	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
,	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
generate	NULL
100-fold	NULL
higher	NULL
concentrations	NULL
of	NULL
inducible	NULL
NO	NULL
at	NULL
levels	NULL
comparable	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
NO	NULL
released	NULL
by	NULL
GSNO	NULL
in	NULL
our	NULL
study	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
higher	NULL
concentrations	NULL
of	NULL
NO	NULL
could	NULL
be	NULL
66	NULL
De	NULL
Caterina	NULL
et	NULL
al	NULL
.	NULL

A	NULL
FO	NULL
c1ss	NULL
AP-1	NULL
gata	NULL
NF-xB	NULL
TaTAA	NULL
F3	NULL
own—CHM	NULL
NF-x8B	NULL
TATAA	NULL
TATAA	NULL
B	NULL
>	NULL
.4	NULL
40007	NULL
I	NULL
E	NULL
n	NULL
E	NULL
N	NULL
=	NULL
3	NULL
juut	NULL
E5	NULL
sooo	NULL
@	NULL
CONTROL	NULL
<	NULL
Q	NULL
TNF	NULL
s	NULL
B	NULL
TNF	NULL
+	NULL
GSNO	NULL
W	NULL
2000	NULL
E	NULL
la	NULL
jut	NULL
a	NULL
i=	NULL
)	NULL
10007	NULL
(	NULL
S	NULL
R4	NULL
,	NULL
|_	NULL
.	NULL

:	NULL
wi	NULL
Fel	NULL
mink	NULL
FFA	NULL
po.CAT	NULL
-	NULL
pFO.CAT	NULL
-	NULL
pF3.CAT	NULL
-	NULL
pF4.CAT	NULL
Figure	NULL
8	NULL
.	NULL

(	NULL
A	NULL
)	NULL
VCAM-1	NULL
promoter	NULL
CAT	NULL
reporter	NULL
constructs	NULL
used	NULL
in	NULL
transfection	NULL
experiments	NULL
.	NULL

The	NULL
length	NULL
of	NULL
the	NULL
promoter	NULL
upstream	NULL
from	NULL
the	NULL
initiation	NULL
start	NULL
site	NULL
is	NULL
denoted	NULL
in	NULL
base	NULL
pairs	NULL
along	NULL
with	NULL
putative	NULL
nuclear	NULL
protein	NULL
binding	NULL
domains	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transfection	NULL
studies	NULL
in	NULL
bovine	NULL
aortic	NULL
endothelial	NULL
cells	NULL
using	NULL
promoterless	NULL
construct	NULL
(	NULL
po.CAT	NULL
)	NULL
,	NULL
highly	NULL
expressed	NULL
construct	NULL
(	NULL
pSV40.CAT	NULL
)	NULL
,	NULL
and	NULL
various	NULL
truncated	NULL
VCAM-1	NULL
promoter	NULL
con-structs	NULL
.	NULL

*	NULL
Significant	NULL
difference	NULL
(	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
between	NULL
treatment	NULL
with	NULL
cytokines	NULL
alone	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
GSNO	NULL
.	NULL

encountered	NULL
by	NULL
cytokine-activated	NULL
endothelial	NULL
cells	NULL
due	NULL
to	NULL
their	NULL
close	NULL
proximity	NULL
to	NULL
smooth	NULL
muscle	NULL
cells	NULL
and	NULL
macrophages	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
and	NULL
the	NULL
potential	NULL
stabilization	NULL
of	NULL
NO	NULL
by	NULL
formation	NULL
of	NULL
potent	NULL
adducts	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
NO	NULL
inhibits	NULL
cytokine-induced	NULL
expression	NULL
of	NULL
VCAM-1	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
involve	NULL
stimulation	NULL
of	NULL
guanylyl	NULL
cyclase	NULL
since	NULL
treatment	NULL
with	NULL
cGMP	NULL
analogues	NULL
does	NULL
not	NULL
reduce	NULL
VCAM-1	NULL
expression	NULL
.	NULL

Nor	NULL
does	NULL
NO	NULL
affect	NULL
the	NULL
post-transcriptional	NULL
half-life	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
actinomycin	NULL
D	NULL
studies	NULL
.	NULL

Rather	NULL
,	NULL
nuclear	NULL
run-on	NULL
assays	NULL
and	NULL
transfection	NULL
studies	NULL
demonstrate	NULL
that	NULL
NO	NULL
represses	NULL
VCAM-1	NULL
gene	NULL
transcription	NULL
,	NULL
in	NULL
part	NULL
,	NULL
by	NULL
inhibiting	NULL
nuclear	NULL
binding	NULL
protein	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

However	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
[	NULL
-755	NULL
]	NULL
FO.CAT	NULL
had	NULL
a	NULL
higher	NULL
CAT	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
TNFa	NULL
compared	NULL
with	NULL
[	NULL
-98	NULL
]	NULL
F3.CAT	NULL
which	NULL
contained	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
but	NULL
not	NULL
AP-1	NULL
or	NULL
GATA	NULL
sites	NULL
,	NULL
suggests	NULL
that	NULL
full	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
requires	NULL
the	NULL
participation	NULL
of	NULL
nuclear	NULL
binding	NULL
proteins	NULL
such	NULL
as	NULL
c-	NULL
fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
GATA	NULL
.	NULL

Inhibition	NULL
of	NULL
[	NULL
-98	NULL
]	NULL
F3.CAT	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
NO	NULL
suggests	NULL
that	NULL
inactivation	NULL
of	NULL
NF-kB	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
mechanisms	NULL
underlying	NULL
NO	NULL
's	NULL
inhibitory	NULL
effects	NULL
on	NULL
VCAM-1	NULL
expression	NULL
.	NULL

Indeed	NULL
,	NULL
other	NULL
investigators	NULL
have	NULL
found	NULL
that	NULL
activation	NULL
of	NULL
NF-kB	NULL
plays	NULL
«	NULL
«	NULL
-	NULL
Supershift	NULL
«	NULL
«	NULL
-	NULL
NF-	NULL
«	NULL
xB	NULL
Figure	NULL
9	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
showing	NULL
the	NULL
effects	NULL
of	NULL
GSNO	NULL
(	NULL
0.2	NULL
x	NULL
107	NULL
mol/liter	NULL
)	NULL
on	NULL
time-dependent	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
TNFa	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Specificity	NULL
was	NULL
determined	NULL
by	NULL
addition	NULL
of	NULL
p65	NULL
or	NULL
p50	NULL
antibodies	NULL
(	NULL
supershift	NULL
)	NULL
or	NULL
unlabeled	NULL
(	NULL
cold	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
to	NULL
the	NULL
nuclear	NULL
extracts	NULL
.	NULL

Three	NULL
separate	NULL
experiments	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

a	NULL
major	NULL
role	NULL
in	NULL
transcriptionally	NULL
inducing	NULL
the	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
and	NULL
various	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-6	NULL
and	NULL
IL-8	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
TNFa	NULL
is	NULL
thought	NULL
to	NULL
occur	NULL
,	NULL
in	NULL
part	NULL
,	NULL
via	NULL
reactive	NULL
oxygen	NULL
species	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
,	NULL
NO	NULL
may	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
scavenging	NULL
and	NULL
inactivating	NULL
superoxide	NULL
anion	NULL
.	NULL

The	NULL
reaction	NULL
of	NULL
NO	NULL
and	NULL
superoxide	NULL
anion	NULL
is	NULL
one	NULL
of	NULL
the	NULL
fastest	NULL
reactions	NULL
known	NULL
in	NULL
biological	NULL
systems	NULL
and	NULL
is	NULL
almost	NULL
three	NULL
times	NULL
faster	NULL
than	NULL
that	NULL
between	NULL
superoxide	NULL
anion	NULL
and	NULL
SOD	NULL
(	NULL
43	NULL
)	NULL
.	NULL

However	NULL
,	NULL
at	NULL
biological	NULL
pH	NULL
,	NULL
the	NULL
spontaneous	NULL
dismutation	NULL
of	NULL
superoxide	NULL
anion	NULL
may	NULL
be	NULL
sufficiently	NULL
rapid	NULL
that	NULL
addition	NULL
of	NULL
SOD	NULL
may	NULL
not	NULL
appreciably	NULL
alter	NULL
the	NULL
formation	NULL
of	NULL
hydrogen	NULL
peroxide	NULL
.	NULL

Our	NULL
findings	NULL
that	NULL
catalase	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
SOD	NULL
,	NULL
inhibited	NULL
cytokine-induced	NULL
VCAM-1	NULL
mRNA	NULL
expression	NULL
agrees	NULL
with	NULL
reports	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
more	NULL
hydrogen	NULL
peroxide-sensitive	NULL
rather	NULL
than	NULL
superoxide	NULL
anion-sensitive	NULL
transcription	NULL
factor	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
NO	NULL
to	NULL
inhibit	NULL
monocyte	NULL
adhesion	NULL
to	NULL
endothelium	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
observations	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Bath	NULL
and	NULL
co-workers	NULL
(	NULL
9	NULL
)	NULL
reported	NULL
that	NULL
NO	NULL
inhibits	NULL
monocyte	NULL
adhesion	NULL
to	NULL
endothelium	NULL
in	NULL
vitro	NULL
,	NULL
without	NULL
altering	NULL
expression	NULL
of	NULL
CD11b/	NULL
CD18	NULL
,	NULL
one	NULL
of	NULL
the	NULL
cognate	NULL
ligands	NULL
on	NULL
monocytes	NULL
for	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecules	NULL
.	NULL

In	NULL
experiments	NULL
superfusing	NULL
a	NULL
cat	NULL
mesenteric	NULL
preparation	NULL
with	NULL
inhibitors	NULL
of	NULL
NO	NULL
production	NULL
(	NULL
L-NMA	NULL
and	NULL
L-nitro-arginine	NULL
methyl	NULL
ester	NULL
[	NULL
L-NAME	NULL
]	NULL
)	NULL
,	NULL
Kubes	NULL
and	NULL
collaborators	NULL
(	NULL
7	NULL
)	NULL
also	NULL
showed	NULL
that	NULL
such	NULL
inhibitors	NULL
increase	NULL
leukocyte	NULL
(	NULL
mostly	NULL
neutrophil	NULL
)	NULL
adhesion	NULL
to	NULL
mesenteric	NULL
venules	NULL
.	NULL

They	NULL
also	NULL
showed	NULL
that	NULL
increased	NULL
expression	NULL
of	NULL
CD11b/CDI18	NULL
on	NULL
the	NULL
leukocyte	NULL
surface	NULL
could	NULL
not	NULL
account	NULL
for	NULL
L-NAME	NULL
s	NULL
effect	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Other	NULL
in	NULL
vivo	NULL
studies	NULL
by	NULL
Kurose	NULL
and	NULL
colleagues	NULL
(	NULL
45	NULL
)	NULL
have	NULL
also	NULL
documented	NULL
modulation	NULL
of	NULL
monocyte	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
by	NULL
L-NAME	NULL
and	NULL
reversal	NULL
by	NULL
cGMP	NULL
analogues	NULL
.	NULL

This	NULL
result	NULL
contrasts	NULL
with	NULL
our	NULL
finding	NULL
that	NULL
cGMP	NULL
analogues	NULL
do	NULL
not	NULL
affect	NULL
cytokine-induced	NULL
expression	NULL
of	NULL
VCAM-1	NULL
.	NULL

Several	NULL
possibilities	NULL
could	NULL
account	NULL
for	NULL
this	NULL
difference	NULL
.	NULL

First	NULL
,	NULL
these	NULL
in	NULL
vivo	NULL
studies	NULL
showed	NULL
induction	NULL
of	NULL
endothelial-leukocyte	NULL
adhesion	NULL
by	NULL
L-NAME	NULL
rather	NULL
than	NULL
by	NULL
cytokines	NULL
.	NULL

Perhaps	NULL
induction	NULL
of	NULL
VCAM-1	NULL
by	NULL
L-NAME	NULL
is	NULL
amenable	NULL
to	NULL
reversal	NULL
by	NULL
cGMP	NULL
analogues	NULL
.	NULL

Second	NULL
,	NULL
these	NULL
studies	NULL
can	NULL
not	NULL
separate	NULL
cGMP	NULL
effects	NULL
on	NULL
hemodynamics	NULL
and/or	NULL
leukocytes	NULL
from	NULL
direct	NULL
alterations	NULL
in	NULL
endothelial	NULL
functions	NULL
.	NULL

Furthermore	NULL
,	NULL
induction	NULL
of	NULL
other	NULL
adhesion	NULL
molecules	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
ICAM-1	NULL
or	NULL
E-selectin	NULL
)	NULL
by	NULL
L-NAME	NULL
treatment	NULL
may	NULL
depend	NULL
partially	NULL
on	NULL
cGMP-dependent	NULL
pathways	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
by	NULL
selectively	NULL
exposing	NULL
cultured	NULL
endothelial	NULL
cells	NULL
to	NULL
NO	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
endothelial	NULL
cells	NULL
as	NULL
a	NULL
potential	NULL
target	NULL
of	NULL
NO	NULL
's	NULL
effect	NULL
in	NULL
limiting	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
VCAM-1	NULL
.	NULL

As	NULL
mentioned	NULL
previously	NULL
,	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
,	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
,	NULL
have	NULL
recently	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
endogenous	NULL
NO	NULL
as	NULL
an	NULL
antiatherogenic	NULL
autacoid	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Our	NULL
in	NULL
vitro	NULL
study	NULL
provides	NULL
a	NULL
link	NULL
between	NULL
NO	NULL
production	NULL
and	NULL
monocyte	NULL
adhesion	NULL
and	NULL
offers	NULL
clues	NULL
as	NULL
to	NULL
the	NULL
mechanism	NULL
of	NULL
such	NULL
an	NULL
effect	NULL
.	NULL

Local	NULL
generation	NULL
of	NULL
sufficiently	NULL
high	NULL
amounts	NULL
of	NULL
NO	NULL
by	NULL
either	NULL
endothelial	NULL
cells	NULL
themselves	NULL
or	NULL
by	NULL
other	NULL
neighboring	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
inflammatory	NULL
stimuli	NULL
could	NULL
provide	NULL
a	NULL
homeostatic	NULL
regulation	NULL
of	NULL
monocyte	NULL
adhesion	NULL
under	NULL
physiological	NULL
conditions	NULL
within	NULL
the	NULL
vessel	NULL
wall	NULL
.	NULL

Endothelial	NULL
dysfunction	NULL
resulting	NULL
in	NULL
reduced	NULL
level	NULL
of	NULL
NO	NULL
activity	NULL
can	NULL
lead	NULL
not	NULL
only	NULL
to	NULL
an	NULL
imbalance	NULL
in	NULL
vascular	NULL
tone	NULL
,	NULL
favoring	NULL
acute	NULL
vasoconstriction	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
,	NULL
but	NULL
can	NULL
also	NULL
impair	NULL
an	NULL
endogenous	NULL
negative	NULL
feedback	NULL
loop	NULL
that	NULL
limits	NULL
VCAM-1	NULL
expression	NULL
,	NULL
leukocyte	NULL
adhesion	NULL
,	NULL
and	NULL
atherogenesis	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
exogenous	NULL
as	NULL
well	NULL
as	NULL
endogenous	NULL
sources	NULL
of	NULL
NO	NULL
can	NULL
limit	NULL
the	NULL
degree	NULL
of	NULL
endothelial	NULL
activation	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
NO	NULL
to	NULL
inhibit	NULL
the	NULL
expression	NULL
of	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecules	NULL
and	NULL
certain	NULL
proinflammatory	NULL
cytokines	NULL
makes	NULL
it	NULL
a	NULL
potentially	NULL
important	NULL
regulator	NULL
of	NULL
inflammatory	NULL
trafficking	NULL
within	NULL
the	NULL
vessel	NULL
wall	NULL
.	NULL

Acknowledgments	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Maria	NULL
Muszynski	NULL
(	NULL
cell	NULL
culture	NULL
)	NULL
,	NULL
Peter	NULL
Lopez	NULL
(	NULL
flow	NULL
cytometry	NULL
studies	NULL
)	NULL
,	NULL
Francis	NULL
W.	NULL
Luscinskas	NULL
(	NULL
monocyte	NULL
preparations	NULL
)	NULL
,	NULL
Tucker	NULL
Collins	NULL
and	NULL
Andrew	NULL
Neish	NULL
(	NULL
VCAM-1	NULL
promoter	NULL
constructs	NULL
)	NULL
,	NULL
Peter	NULL
LoMedico	NULL
(	NULL
for	NULL
providing	NULL
IL-la	NULL
)	NULL
,	NULL
and	NULL
David	NULL
G.	NULL
Harrison	NULL
(	NULL
for	NULL
helpful	NULL
discussions	NULL
regarding	NULL
GSNO	NULL
)	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
HL-48743	NULL
(	NULL
P.	NULL
Libby	NULL
)	NULL
,	NULL
HL-36028	NULL
(	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
)	NULL
,	NULL
and	NULL
HL-05280	NULL
(	NULL
J.	NULL
K.	NULL
Liao	NULL
)	NULL
,	NULL
by	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
Grant-in-Aid	NULL
Award	NULL
(	NULL
J.	NULL
K.	NULL
Liao	NULL
)	NULL
,	NULL
and	NULL
by	NULL
contributions	NULL
from	NULL
Italian	NULL
Consiglio	NULL
Nazionale	NULL
delle	NULL
Ricerche	NULL
and	NULL
Fondazione	NULL
per	NULL
la	NULL
Ricerca	NULL
Medica	NULL
(	NULL
R.	NULL
De	NULL
Caterina	NULL
)	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Ignarro	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

1990	NULL
.	NULL

Biosynthesis	NULL
and	NULL
metabolism	NULL
of	NULL
endothelium-derived	NULL
nitric	NULL
oxide	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Pharmacol	NULL
.	NULL

Toxicol	NULL
.	NULL

30:535-560	NULL
.	NULL

2	NULL
.	NULL

Moncada	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
M.	NULL
J.	NULL
Palmer	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Higgs	NULL
.	NULL

1991	NULL
.	NULL

Nitric	NULL
oxide	NULL
:	NULL
physiology	NULL
,	NULL
pathophysiology	NULL
,	NULL
and	NULL
pharmacology	NULL
.	NULL

Pharmacol	NULL
.	NULL

Rev	NULL
.	NULL

43:109-142	NULL
.	NULL

3	NULL
.	NULL

Ignarro	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

1991	NULL
.	NULL

Heme-dependent	NULL
activation	NULL
of	NULL
guanylate	NULL
cyclase	NULL
by	NULL
nitric	NULL
oxide	NULL
:	NULL
a	NULL
novel	NULL
signal	NULL
transduction	NULL
mechanism	NULL
.	NULL

Blood	NULL
Vessels	NULL
.	NULL

28:67-73	NULL
.	NULL

4	NULL
.	NULL

Radomski	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
R.	NULL
M.	NULL
Palmer	NULL
,	NULL
and	NULL
S.	NULL
Moncada	NULL
.	NULL

1990	NULL
.	NULL

An	NULL
L-arginine/	NULL
Nitric	NULL
Oxide	NULL
and	NULL
Endothelial	NULL
Leukocyte	NULL
Adhesion	NULL
Molecules	NULL
__	NULL
67	NULL
nitric	NULL
oxide	NULL
pathway	NULL
present	NULL
in	NULL
human	NULL
platelets	NULL
regulates	NULL
aggregation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

$	NULL
7:5193-5197	NULL
.	NULL

5	NULL
.	NULL

Garg	NULL
,	NULL
U.	NULL
C.	NULL
,	NULL
and	NULL
A.	NULL
Hasid	NULL
.	NULL

1989	NULL
.	NULL

Nitric	NULL
oxide-generating	NULL
vasodilators	NULL
and	NULL
8-bromo-cyclic	NULL
guanosine	NULL
monophosphate	NULL
inhibit	NULL
mitogenesis	NULL
and	NULL
proliferation	NULL
of	NULL
cultured	NULL
rat	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

83:1774-1777	NULL
.	NULL

6	NULL
.	NULL

Nakaki	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Nakayama	NULL
,	NULL
and	NULL
R.	NULL
Kato	NULL
.	NULL

1990	NULL
.	NULL

Inhibition	NULL
by	NULL
nitric	NULL
oxide	NULL
and	NULL
nitric	NULL
oxide-producing	NULL
vasodilators	NULL
of	NULL
DNA	NULL
synthesis	NULL
in	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

Kur	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

189:347-353	NULL
.	NULL

7	NULL
.	NULL

Kubes	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Suzuki	NULL
,	NULL
and	NULL
D.	NULL
N.	NULL
Granger	NULL
.	NULL

1991	NULL
.	NULL

Nitric	NULL
oxide	NULL
:	NULL
an	NULL
endogenous	NULL
modulator	NULL
of	NULL
leukocyte	NULL
adhesion	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

88:4651-4655	NULL
.	NULL

8	NULL
.	NULL

Tsao	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
L.	NULL
M.	NULL
McEvoy	NULL
,	NULL
H.	NULL
Drexler	NULL
,	NULL
E.	NULL
C.	NULL
Butcher	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Cooke	NULL
.	NULL

1994	NULL
.	NULL

Enhanced	NULL
endothelial	NULL
adhesiveness	NULL
in	NULL
hypercholesterolemia	NULL
is	NULL
attenuated	NULL
by	NULL
L-arginine	NULL
.	NULL

Circulation	NULL
.	NULL

89:2176-2182	NULL
.	NULL

9	NULL
.	NULL

Bath	NULL
,	NULL
P.	NULL
M.	NULL
W.	NULL
,	NULL
D.	NULL
G.	NULL
Hassal	NULL
,	NULL
A.-M.	NULL
Gladwin	NULL
,	NULL
R.	NULL
M.	NULL
J.	NULL
Palmer	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Martin	NULL
.	NULL

1991	NULL
.	NULL

Nitric	NULL
oxide	NULL
and	NULL
prostacyclin	NULL
:	NULL
divergence	NULL
of	NULL
inhibitory	NULL
effects	NULL
on	NULL
monocyte	NULL
chemotaxis	NULL
and	NULL
adhesion	NULL
to	NULL
endothelium	NULL
in	NULL
vitro	NULL
.	NULL

Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

11:254-260	NULL
.	NULL

10	NULL
.	NULL

Cooke	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
A.	NULL
H.	NULL
Singer	NULL
,	NULL
P.	NULL
Tsao	NULL
,	NULL
P.	NULL
Zera	NULL
,	NULL
R.	NULL
A.	NULL
Rowan	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Billingham	NULL
.	NULL

1992	NULL
.	NULL

Antiatherogenic	NULL
effects	NULL
of	NULL
L-arginine	NULL
in	NULL
the	NULL
hypercholesterol-emic	NULL
rabbit	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90:1168-1172	NULL
.	NULL

11	NULL
.	NULL

Li	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
I.	NULL
Cybulsky	NULL
,	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
P.	NULL
Libby	NULL
.	NULL

1993	NULL
.	NULL

An	NULL
atherogenic	NULL
diet	NULL
rapidly	NULL
induces	NULL
VCAM-1	NULL
,	NULL
a	NULL
cytokine-regulatable	NULL
mononuclear	NULL
leukocyte	NULL
adhesion	NULL
molecule	NULL
,	NULL
in	NULL
rabbit	NULL
aortic	NULL
endothelium	NULL
.	NULL

Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

13:197-204	NULL
.	NULL

12	NULL
.	NULL

Bevilacqua	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
J.	NULL
S.	NULL
Pober	NULL
,	NULL
D.	NULL
L.	NULL
Mendrick	NULL
,	NULL
R.	NULL
S.	NULL
Cotran	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
1987	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
inducible	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

84:9238-9242	NULL
.	NULL

13	NULL
.	NULL

Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1990	NULL
.	NULL

Adhesion	NULL
receptors	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

346:425-434	NULL
.	NULL

14	NULL
.	NULL

Cybuisky	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Endothelial	NULL
expression	NULL
of	NULL
a	NULL
mononuclear	NULL
leukocyte	NULL
adhesion	NULL
molecule	NULL
during	NULL
atherogenesis	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

251:788-791	NULL
.	NULL

15	NULL
.	NULL

Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

Traffic	NULL
signals	NULL
for	NULL
lymphocyte	NULL
recirculation	NULL
and	NULL
leukocyte	NULL
emigration	NULL
:	NULL
the	NULL
multistep	NULL
paradigm	NULL
.	NULL

Cell	NULL
.	NULL

76:301-314	NULL
.	NULL

16	NULL
.	NULL

Kowaluk	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
H.	NULL
L.	NULL
Fung	NULL
.	NULL

1990	NULL
.	NULL

Spontaneous	NULL
liberation	NULL
of	NULL
nitric	NULL
oxide	NULL
can	NULL
not	NULL
account	NULL
for	NULL
in	NULL
vitro	NULL
vascular	NULL
relaxation	NULL
by	NULL
S-nitrosothiols	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

Exp	NULL
.	NULL

Ther	NULL
.	NULL

255:1256-1264	NULL
.	NULL

17	NULL
.	NULL

Walther	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

Wade	NULL
,	NULL
D.	NULL
Warburton	NULL
,	NULL
and	NULL
H.	NULL
J.	NULL
Forman	NULL
.	NULL

1991	NULL
.	NULL

Augmentation	NULL
of	NULL
superoxide	NULL
dismutase	NULL
and	NULL
catalase	NULL
activity	NULL
in	NULL
alveolar	NULL
type	NULL
II	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

4364-368	NULL
.	NULL

18	NULL
.	NULL

Libby	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
M.	NULL
Ordovas	NULL
,	NULL
K.	NULL
R.	NULL
Auger	NULL
,	NULL
A.	NULL
H.	NULL
Robbins	NULL
,	NULL
L.	NULL
K.	NULL
Birinyi	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1986	NULL
.	NULL

Endotoxin	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
induce	NULL
interleukin-1	NULL
gene	NULL
expression	NULL
in	NULL
adult	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

124:179-185	NULL
.	NULL

19	NULL
.	NULL

Warmer	NULL
,	NULL
S.	NULL
J.	NULL
C.	NULL
,	NULL
G.	NULL
B.	NULL
Friedman	NULL
,	NULL
and	NULL
P.	NULL
Libby	NULL
.	NULL

1989	NULL
.	NULL

Regulation	NULL
of	NULL
major	NULL
histocompatibility	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

Arteriosclerosis	NULL
.	NULL

9:279-288	NULL
.	NULL

20	NULL
.	NULL

Pober	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
,	NULL
L.	NULL
A.	NULL
Lapierre	NULL
,	NULL
D.	NULL
L.	NULL
Mendrick	NULL
,	NULL
W.	NULL
Fiers	NULL
,	NULL
R.	NULL
Rothlein	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1986	NULL
.	NULL

Overlapping	NULL
patterns	NULL
of	NULL
activation	NULL
of	NULL
human	NULL
endothelial	NULL
cells	NULL
by	NULL
interleukin	NULL
1	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
and	NULL
immune	NULL
interferon	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

137:1893-1896	NULL
.	NULL

21	NULL
.	NULL

Libby	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
J.	NULL
C.	NULL
Warner	NULL
,	NULL
and	NULL
G.	NULL
B.	NULL
Friedman	NULL
.	NULL

1988	NULL
.	NULL

Interleukin	NULL
1	NULL
:	NULL
a	NULL
mitogen	NULL
for	NULL
human	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
that	NULL
induces	NULL
the	NULL
release	NULL
of	NULL
growth-inhibitory	NULL
prostanoids	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

81:487-498	NULL
.	NULL

22	NULL
.	NULL

Kohase	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Henriksen-De	NULL
Stefano	NULL
,	NULL
L.	NULL
T.	NULL
May	NULL
,	NULL
J.	NULL
Vilcek	NULL
,	NULL
and	NULL
P.	NULL
B.	NULL
Sehgal	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
P	NULL
;	NULL
-interferon	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
:	NULL
a	NULL
homeostatic	NULL
mechanism	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
proliferation	NULL
.	NULL

Cell	NULL
.	NULL

45:659-666	NULL
.	NULL

23	NULL
.	NULL

Doherty	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
G.	NULL
P.	NULL
Downey	NULL
,	NULL
G.	NULL
S.	NULL
Worthen	NULL
,	NULL
C.	NULL
Haslett	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Henson	NULL
.	NULL

1988	NULL
.	NULL

Monocyte	NULL
retention	NULL
and	NULL
migration	NULL
in	NULL
pulmonary	NULL
inflammation	NULL
;	NULL
requirement	NULL
for	NULL
neutrophils	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

59:200-213	NULL
.	NULL

24	NULL
.	NULL

Luscinskas	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
G.	NULL
S.	NULL
Kansas	NULL
,	NULL
H.	NULL
Ding	NULL
,	NULL
P.	NULL
Pizcueta	NULL
,	NULL
B.	NULL
E.	NULL
Schleiffen-baum	NULL
,	NULL
T.	NULL
F.	NULL
Tedder	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Monocyte	NULL
rolling	NULL
,	NULL
arrest	NULL
and	NULL
spreading	NULL
on	NULL
IL-4-activated	NULL
vascular	NULL
endothelium	NULL
under	NULL
flow	NULL
is	NULL
mediated	NULL
via	NULL
sequential	NULL
action	NULL
of	NULL
L-selectin	NULL
,	NULL
Bl-integrins	NULL
,	NULL
and	NULL
B2-integrins	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

125:1417-1427	NULL
.	NULL

68	NULL
De	NULL
Caterina	NULL
et	NULL
al	NULL
.	NULL

25	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
A.	NULL
E.	NULL
Przybyla	NULL
,	NULL
R.	NULL
J.	NULL
MacDonald	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1979	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
.	NULL

18:5294-5299	NULL
.	NULL

26	NULL
.	NULL

Liao	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
W.	NULL
S.	NULL
Shin	NULL
,	NULL
W.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Clark	NULL
.	NULL

1995	NULL
.	NULL

Oxidized	NULL
low-density	NULL
lipoprotein	NULL
decreases	NULL
the	NULL
expression	NULL
of	NULL
endothelial	NULL
nitric	NULL
oxide	NULL
synthase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:319-324	NULL
.	NULL

27	NULL
.	NULL

Neish	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
A.	NULL
J.	NULL
Williams	NULL
,	NULL
H.	NULL
J.	NULL
Palmer	NULL
,	NULL
M.	NULL
Z.	NULL
Whitley	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
pro-moter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:1583-1593	NULL
.	NULL

28	NULL
.	NULL

Graham	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
and	NULL
A.	NULL
J	NULL
.	NULL

Van	NULL
der	NULL
Eb	NULL
.	NULL

1973	NULL
.	NULL

Transformation	NULL
of	NULL
rat	NULL
cells	NULL
by	NULL
DNA	NULL
of	NULL
human	NULL
adenovirus	NULL
5	NULL
.	NULL

Virology	NULL
.	NULL

52:456-457	NULL
.	NULL

29	NULL
.	NULL

Seed	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
J.-Y	NULL
.	NULL

Sheen	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
simple	NULL
phase-extraction	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acyltransferase	NULL
activity	NULL
.	NULL

Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

.	NULL

67:271-277	NULL
.	NULL

30	NULL
.	NULL

Edlund	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
D.	NULL
Walker	NULL
,	NULL
P.	NULL
J.	NULL
Barr	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1985	NULL
.	NULL

Cell-specific	NULL
expression	NULL
of	NULL
the	NULL
rat	NULL
insulin	NULL
gene	NULL
:	NULL
evidence	NULL
for	NULL
role	NULL
of	NULL
two	NULL
distinct	NULL
5	NULL
'	NULL
flanking	NULL
elements	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

230:912-916	NULL
.	NULL

31	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

32	NULL
.	NULL

Zar	NULL
,	NULL
J	NULL
.	NULL

1974	NULL
.	NULL

Biostatistical	NULL
Analysis	NULL
.	NULL

Prentice-Hall	NULL
,	NULL
Inc.	NULL
,	NULL
Englewood	NULL
Cliffs	NULL
,	NULL
NJ	NULL
.	NULL

1-736	NULL
.	NULL

33	NULL
.	NULL

Luscinskas	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
M.	NULL
I.	NULL
Cybulsky	NULL
,	NULL
J.-M.	NULL
Kiely	NULL
,	NULL
C.	NULL
$	NULL
.	NULL

Peckins	NULL
,	NULL
V.	NULL
M.	NULL
Davis	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Cytokine-activated	NULL
human	NULL
endothelial	NULL
monolayers	NULL
support	NULL
enhanced	NULL
neutrophil	NULL
transmigration	NULL
via	NULL
a	NULL
mechanism	NULL
involving	NULL
both	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ELAM-1	NULL
)	NULL
and	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1617-1625	NULL
.	NULL

34	NULL
.	NULL

Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

1990	NULL
.	NULL

Interleukin-6	NULL
:	NULL
an	NULL
overview	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:253-278	NULL
.	NULL

35	NULL
.	NULL

Oppenheim	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
C.	NULL
O.	NULL
Zachariae	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1991	NULL
.	NULL

Properties	NULL
of	NULL
the	NULL
novel	NULL
proinflammatory	NULL
supergene	NULL
``	NULL
intercrine	NULL
``	NULL
cytokine	NULL
family	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9:617-648	NULL
.	NULL

36	NULL
.	NULL

Kowaluk	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
H.-L.	NULL
Fung	NULL
.	NULL

1990	NULL
.	NULL

Spontaneous	NULL
liberation	NULL
of	NULL
nitric	NULL
oxide	NULL
can	NULL
not	NULL
account	NULL
for	NULL
in	NULL
vitro	NULL
vascular	NULL
relaxation	NULL
by	NULL
S-nitrosothiols	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

Exp	NULL
.	NULL

Ther	NULL
.	NULL

255:1256-1264	NULL
.	NULL

37	NULL
.	NULL

Radomski	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
D.	NULL
D.	NULL
Rees	NULL
,	NULL
A.	NULL
Dutra	NULL
,	NULL
and	NULL
S.	NULL
Moncada	NULL
.	NULL

1992	NULL
.	NULL

S-nitroso-glutathione	NULL
inhibits	NULL
platelet	NULL
activation	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

107:745-749	NULL
.	NULL

38	NULL
.	NULL

Stamler	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
D.	NULL
I.	NULL
Simon	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Osborne	NULL
,	NULL
M.	NULL
E.	NULL
Mullins	NULL
,	NULL
O.	NULL
Jaraki	NULL
,	NULL
T.	NULL
Michel	NULL
,	NULL
D.	NULL
J.	NULL
Singel	NULL
,	NULL
and	NULL
J.	NULL
Loscalzo	NULL
.	NULL

1992	NULL
.	NULL

S-nitrosylation	NULL
of	NULL
proteins	NULL
with	NULL
nitric	NULL
oxide	NULL
:	NULL
synthesis	NULL
and	NULL
characterization	NULL
of	NULL
biologically	NULL
active	NULL
compounds	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:444~448	NULL
.	NULL

39	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-6	NULL
gene	NULL
expression	NULL
through	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2327-2334	NULL
.	NULL

40	NULL
.	NULL

Kunsch	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
K.	NULL
Lang	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Shannon	NULL
.	NULL

1994	NULL
.	NULL

Synergistic	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
by	NULL
NF-kappa	NULL
B	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
and	NULL
NF-IL-6	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:153-164	NULL
.	NULL

41	NULL
.	NULL

Marui	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
K.	NULL
Offermann	NULL
,	NULL
R.	NULL
Swerlick	NULL
,	NULL
C.	NULL
Kunsck	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
M.	NULL
Ahmad	NULL
,	NULL
R.	NULL
W.	NULL
Alexander	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Medford	NULL
.	NULL

1993	NULL
.	NULL

Vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
and	NULL
expression	NULL
are	NULL
regulated	NULL
through	NULL
an	NULL
antioxidant-sensitive	NULL
mechanism	NULL
in	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

92:1866-1874	NULL
.	NULL

42	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Rieber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

10:2247-2258	NULL
.	NULL

43	NULL
.	NULL

Huie	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
and	NULL
S.	NULL
Padmaja	NULL
.	NULL

1993	NULL
.	NULL

Reaction	NULL
of	NULL
nitric	NULL
oxide	NULL
with	NULL
superoxide	NULL
anion	NULL
.	NULL

Free	NULL
Radical	NULL
Res	NULL
.	NULL

Commun	NULL
.	NULL

18:195-200	NULL
.	NULL

44	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
K.	NULL
Albermann	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
Factor-	NULL
«	NULL
B	NULL
:	NULL
an	NULL
oxidative	NULL
stress-responsive	NULL
transcription	NULL
factor	NULL
of	NULL
eukaryotic	NULL
cells	NULL
.	NULL

Free	NULL
Radical	NULL
Res	NULL
.	NULL

Commun	NULL
.	NULL

17:221-237	NULL
.	NULL

45	NULL
.	NULL

Kurose	NULL
,	NULL
I.	NULL
,	NULL
P.	NULL
Kubes	NULL
,	NULL
R.	NULL
Wolf	NULL
,	NULL
D.	NULL
C.	NULL
Anderson	NULL
,	NULL
J.	NULL
Paulson	NULL
,	NULL
M.	NULL
Miyasaka	NULL
,	NULL
and	NULL
D.	NULL
N.	NULL
Granger	NULL
.	NULL

1993	NULL
.	NULL

Inhibition	NULL
of	NULL
nitric	NULL
oxide	NULL
production	NULL
.	NULL

Mechanisms	NULL
of	NULL
vascular	NULL
albumin	NULL
leakage	NULL
.	NULL

Circ	NULL
.	NULL

Res	NULL
.	NULL

73:164-171	NULL
.	NULL

46	NULL
.	NULL

Cooke	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Tsao	NULL
.	NULL

1994	NULL
.	NULL

Is	NULL
NO	NULL
an	NULL
endogenous	NULL
antiatherogenic	NULL
molecule	NULL
?	NULL

Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

14:653-655	NULL
.	NULL

